<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84168</article-id><article-id pub-id-type="doi">10.7554/eLife.84168</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Identification of a weight loss-associated causal eQTL in <italic>MTIF3</italic> and the effects of <italic>MTIF3</italic> deficiency on human adipocyte function</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-295743"><name><surname>Huang</surname><given-names>Mi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6938-5322</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295744"><name><surname>Coral</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295746"><name><surname>Ardalani</surname><given-names>Hamidreza</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295747"><name><surname>Spegel</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295748"><name><surname>Saadat</surname><given-names>Alham</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188628"><name><surname>Claussnitzer</surname><given-names>Melina</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242643"><name><surname>Mulder</surname><given-names>Hindrik</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6593-8417</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-295745"><name><surname>Franks</surname><given-names>Paul W</given-names></name><email>paul.franks@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-295610"><name><surname>Kalamajski</surname><given-names>Sebastian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6600-9302</contrib-id><email>sebastian.kalamajski@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012a77v79</institution-id><institution>Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Clinical Research Centre, Lund University</institution></institution-wrap><addr-line><named-content content-type="city">Malmö</named-content></addr-line><country>Sweden</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012a77v79</institution-id><institution>Department of Chemistry, Centre for Analysis and Synthesis, Lund University</institution></institution-wrap><addr-line><named-content content-type="city">Lund</named-content></addr-line><country>Sweden</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05a0ya142</institution-id><institution>Metabolism Program, Broad Institute of MIT and Harvard</institution></institution-wrap><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012a77v79</institution-id><institution>Unit of Molecular Metabolism, Department of Clinical Sciences, Clinical Research Centre, Lund University</institution></institution-wrap><addr-line><named-content content-type="city">Malmö</named-content></addr-line><country>Sweden</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03vek6s52</institution-id><institution>Department of Nutrition, Harvard T.H. Chan School of Public Health</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Seldin</surname><given-names>Marcus M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gyf1771</institution-id><institution>University of California</institution></institution-wrap><addr-line><named-content content-type="city">Irvine</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>James</surname><given-names>David E</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0384j8v12</institution-id><institution>University of Sydney</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>06</day><month>03</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e84168</elocation-id><history><date date-type="received" iso-8601-date="2022-10-12"><day>12</day><month>10</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-03-05"><day>05</day><month>03</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-10-17"><day>17</day><month>10</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.10.16.512435"/></event></pub-history><permissions><copyright-statement>© 2023, Huang et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Huang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-84168-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-84168-figures-v2.pdf"/><abstract><p>Genetic variation at the <italic>MTIF3</italic> (Mitochondrial Translational Initiation Factor 3) locus has been robustly associated with obesity in humans, but the functional basis behind this association is not known. Here, we applied luciferase reporter assay to map potential functional variants in the haplotype block tagged by rs1885988 and used CRISPR-Cas9 to edit the potential functional variants to confirm the regulatory effects on <italic>MTIF3</italic> expression. We further conducted functional studies on MTIF3-deficient differentiated human white adipocyte cell line (hWAs-iCas9), generated through inducible expression of CRISPR-Cas9 combined with delivery of synthetic <italic>MTIF3</italic>-targeting guide RNA. We demonstrate that rs67785913-centered DNA fragment (in LD with rs1885988, <italic>r</italic><sup>2</sup> &gt; 0.8) enhances transcription in a luciferase reporter assay, and CRISPR-Cas9-edited rs67785913 CTCT cells show significantly higher <italic>MTIF3</italic> expression than rs67785913 CT cells. Perturbed <italic>MTIF3</italic> expression led to reduced mitochondrial respiration and endogenous fatty acid oxidation, as well as altered expression of mitochondrial DNA-encoded genes and proteins, and disturbed mitochondrial OXPHOS complex assembly. Furthermore, after glucose restriction, the <italic>MTIF3</italic> knockout cells retained more triglycerides than control cells. This study demonstrates an adipocyte function-specific role of <italic>MTIF3</italic>, which originates in the maintenance of mitochondrial function, providing potential explanations for why <italic>MTIF3</italic> genetic variation at rs67785913 is associated with body corpulence and response to weight loss interventions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>obesity</kwd><kwd>CRISPR</kwd><kwd>eQTL</kwd><kwd>adipocyte</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>ERC-2015-CoG -681742 NASCENT</award-id><principal-award-recipient><name><surname>Franks</surname><given-names>Paul W</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Mulder</surname><given-names>Hindrik</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>LUDC-IRC</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Mulder</surname><given-names>Hindrik</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004543</institution-id><institution>China Scholarship Council</institution></institution-wrap></funding-source><award-id>201708420158</award-id><principal-award-recipient><name><surname>Huang</surname><given-names>Mi</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006189</institution-id><institution>Albert Påhlsson Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kalamajski</surname><given-names>Sebastian</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003173</institution-id><institution>The Crafoord Foundation</institution></institution-wrap></funding-source><award-id>20210571</award-id><principal-award-recipient><name><surname>Kalamajski</surname><given-names>Sebastian</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>MTIF3 safeguards mitochondrial electron transport chain assembly in adipocytes, and affects thus adipocyte fatty acid oxidation ability, which can explain why MTIF3 genetic variation can influence dietary intervention aimed at weight loss.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Over 650 million people are obese and often suffer from metabolic abnormalities, including dyslipidemia, type 2 diabetes, and hypertension (<xref ref-type="bibr" rid="bib1">Adams et al., 2006</xref>; <xref ref-type="bibr" rid="bib26">May et al., 2020</xref>). It is widely believed that obesity results from an interplay between genetic and environmental factors (<xref ref-type="bibr" rid="bib39">Thomas, 2010</xref>), but the biological mechanisms behind these interactions are poorly understood.</p><p>Genetic variation (rs12016871) at <italic>MTIF3</italic> (encoding the Mitochondrial Translation Initiation Factor 3 protein [<xref ref-type="bibr" rid="bib21">Kuzmenko et al., 2014</xref>]) has been robustly associated with body mass index (BMI) in humans (<xref ref-type="bibr" rid="bib23">Locke et al., 2015</xref>). Several subsequent studies have linked <italic>MTIF3</italic> genetic variation with the response to weight loss interventions, including diet, exercise, and bariatric surgery (<xref ref-type="bibr" rid="bib29">Papandonatos et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Rasmussen-Torvik et al., 2015</xref>), and with weight-related effects of habitual diet (<xref ref-type="bibr" rid="bib28">Nettleton et al., 2015</xref>). For example, analyses in two of the world’s largest randomized controlled weight loss trials (Diabetes Prevention Program [DPP] and Look AHEAD) found that homozygous minor allele carriers (rs1885988) were slightly more prone to weight gain in the control arm, yet achieved significantly greater weight loss at 12-month post-randomization and retained lost weight longer (18–36 months) than major allele carriers (<xref ref-type="bibr" rid="bib29">Papandonatos et al., 2015</xref>). Elsewhere, the same locus has been associated with greater and more sustained weight loss following bariatric surgery (<xref ref-type="bibr" rid="bib33">Rasmussen-Torvik et al., 2015</xref>).</p><p>Mtif3 loss in the mouse results in cardiomyopathy owing to impaired translation initiation from mitochondrial mRNAs and uncoordinated assembly of OXPHOS complexes in heart and skeletal muscle (<xref ref-type="bibr" rid="bib34">Rudler et al., 2019</xref>). In the human hepatocyte-like HepG2 cell line, MTIF3 loss decreases the translation of the mitochondrial-encoded ATP synthase membrane subunit 6 (<italic>ATP6</italic>) mRNA without affecting cellular proliferation (<xref ref-type="bibr" rid="bib8">Chicherin et al., 2020</xref>). No human genomic mutations leading to total MTIF3 deficiency have been reported, but the studies outlined above suggest that <italic>MTIF3</italic> may influence obesity predisposition and weight loss potential by modulating mitochondrial function; thus, <italic>MTIF3</italic> may play a key role in adipose tissue metabolic homeostasis, as adipocyte mitochondria not only provide ATP, but also impact adipocyte-specific biological processes such as adipogenesis, lipid metabolism, thermogenesis, and regulation of whole-body energy homeostasis (<xref ref-type="bibr" rid="bib13">Gregoire et al., 1998</xref>; <xref ref-type="bibr" rid="bib7">Boudina and Graham, 2014</xref>).</p><p>In this study, we aimed to experimentally dissect the molecular mechanisms that could underlie the correlation between <italic>MTIF3</italic> genetic variation and weight loss intervention outcomes. We hypothesized that among the common genetic variants in <italic>MTIF3</italic>, one (or more) is causal for altered <italic>MTIF3</italic> expression. Secondly, we hypothesized that MTIF3 content in human white adipocytes influences adipocyte-specific, obesity-related traits under basal and perturbed metabolic conditions. For the latter, we used glucose restriction to mimic the effects of in vivo lifestyle interventions focused on energy restriction and expenditure.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>rs67785913 is a regulatory variant for <italic>MTIF3</italic> expression</title><p>The <italic>MTIF3</italic> rs1885988 C allele is associated with enhanced weight loss and weight retention following lifestyle intervention trials in DPP and Look AHEAD cohorts (<xref ref-type="bibr" rid="bib29">Papandonatos et al., 2015</xref>). In the GTEx database, the rs1885988 associates with an eQTL in subcutaneous fat (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), with C allele carriers having significantly higher <italic>MTIF3</italic> expression (normalized effect size: 0.15, p = 0.0000032).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Identification of rs67785913 as a causal cis-eQTL for <italic>MTIF3.</italic></title><p>(<bold>A</bold>) Violin plot of <italic>MTIF3</italic> expression in subcutaneous adipose tissue for rs1885988 from Genotype-Tissue Expression (GTEx) Project eQTL. (<bold>B</bold>) Same as in (<bold>A</bold>), but for rs67785913. (<bold>C</bold>) Representative Sanger sequencing traces of rs67785913 CTCT/CTCT and CT/CT clones obtained after CRISPR/Cas9-mediated allele editing and single-cell cloning. (<bold>D</bold>) Normalized <italic>Z</italic>-score plot of luciferase reporter assays using vectors carrying different DNA fragments of the <italic>MTIF3</italic> gene cloned into pGL4.23 luciferase reporter vector. Hypothesis testing was performed by comparing the transcriptional enhancer activity of each of the 12 vectors (F1–12) to the empty vector (minP). All data were plotted as mean ± standard deviation (SD), <italic>n</italic> = 4 independent experiments, p values are presented in each graph; ordinary one-way analysis of variance (ANOVA) was used for statistical analysis. (<bold>E</bold>) Relative <italic>MTIF3</italic> expression (mRNA) in rs67785913 allele-edited cells 2 days before, at, or 2 days post-differentiation induction (day −2, 0, and 2, respectively). <italic>n</italic> = 3 clonal populations for CTCT/CTCT genotype, <italic>n</italic> = 5 clonal populations for CT/CT genotype, error bars show SD. (<bold>F</bold>) as in (<bold>E</bold>), but for <italic>GTF3A</italic> (mRNA) expression. Two-tailed Student’s <italic>t</italic>-test was used; p values are presented in each graph.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>To test if rs67785913 affects adipogenic differentiation in hWAs cells, we differentiated the rs67785913 allele-edited cells (CTCT/CTCT vs. CT/CT) for 12 days.</title><p>We then used qPCR to quantify adipogenesis marker gene expression and mitochondrial content (mtDNA). Neither <italic>PPARG</italic>, <italic>ADIPOQ</italic>, <italic>CEBPA</italic>, <italic>SREBF1</italic>, and <italic>FABP4</italic> gene expression (panels A–E) or mitochondrial content (panel F) were significantly different between the two rs67785913 genotypes. <italic>n</italic> = 3 clonal cell lines with CTCT/CTCT genotype, <italic>n</italic> = 5 clonal cell lines for CT/CT genotype. Error bars show standard deviation. Statistical analyses were performed using paired Student’s <italic>t</italic>-test, and p values are presented in the graphs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig1-figsupp1-v2.tif"/></fig></fig-group><p>To experimentally validate and fine map the potential causal DNA variation in the haplotype block tagged by rs1885988, we looked up all tightly linked (<italic>r</italic><sup>2</sup> &gt; 0.8) single-nucleotide polymorphisms (SNPs) in HaploReg database v4.1 (<xref ref-type="bibr" rid="bib43">Ward and Kellis, 2012</xref>). We then PCR-amplified and cloned 12 DNA fragments from that haploblock, altogether comprising the linked SNP loci, into luciferase reporter plasmids. As shown in <xref ref-type="fig" rid="fig1">Figure 1D</xref>, by comparing the luciferase signals with minimal promoter (minP) construct, only one DNA fragment (F11), encompassing the rs67785913 locus, could enhance luciferase transcription. Coincidentally, the rs67785913 also shows an eQTL effect on <italic>MTIF3</italic> expression in subcutaneous adipose tissue in GTEx database, with the major CT allele associated with lower expression than the minor CTCT allele (normalized effect size: −0.16, p = 3.0 × 10<sup>−8</sup>) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). To demonstrate an allele-specific regulatory effect on <italic>MTIF3</italic> expression, we then used CRISPR-Cas9 to substitute the major CT for the minor CTCT allele at the rs67785913 locus in the pre-adipocyte hWAs cell line. Due to rather low CRISPR editing efficiency of that locus, we needed to genotype over 700 single-cell clones to obtain five CT/CT and three CTCT/CTCT clones without random indels, as confirmed by Sanger sequencing (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). We then examined <italic>MTIF3</italic> expression in these clones at pre- and post-adipogenic differentiation induction, and found rs67785913 CTCT/CTCT to confer higher <italic>MTIF3</italic> expression at all time points (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), although without apparent change on adipogenic differentiation markers (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). As rs67785913 also correlates with an altered <italic>GTF3A</italic> expression in other tissues (e.g., muscle, lung), we also detected, but found no apparent difference in <italic>GTF3A</italic> expression in rs67785913-edited cells (<xref ref-type="fig" rid="fig1">Figure 1F</xref>).</p></sec><sec id="s2-2"><title>Generating inducible Cas9-expressing pre-adipocyte cell line (hWas-iCas9)</title><p>Next, we intended to use the rs67785913-edited cells in functional genomics experiments to examine the phenotypic consequences of the eQTL. To conduct meaningful studies of gene × environment interaction, it is desirable to use similarly differentiated cells with comparable baselines (e.g., similar triglyceride or mitochondrial content). Unfortunately, marginally different passage numbers between control and experimental groups can confound adipogenic differentiation. This problem can originate during single-cell cloning to create genetic knockouts/knockins, and became apparent with our rs67785913 allele-edited cells. While the mean values of adipogenic markers were similar in both rs67785913 genotypes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), the variation between clones of the same genotype precluded the use of these cells in gene × environment studies. To circumvent this, we instead established an inducible Cas9-expressing pre-adipocyte cell line that allowed us to knockout <italic>MTIF3</italic> after completed adipogenic differentiation. As illustrated in <xref ref-type="fig" rid="fig2">Figure 2</xref>, we co-transfected hWAs with two plasmids: one encoding piggyBac transposase, and the other carrying piggyBac transposon-flanked doxycycline-inducible Cas9 and constitutively expressed puromycin resistance genes. In this setup, piggyBac transposase drives the integration of the piggyBac-transposon-flanked genes, and transgenic cells are then selected and expanded in puromycin-supplemented culture medium. We have thus obtained an hWAs cell line with doxycycline-inducible Cas9 expression and maintained adipogenic differentiation capacity (henceforth called hWAs-iCas9). The Cas9-expressing differentiated cells could then be transfected with relatively low molecular weight synthetic single guide RNAs (sgRNAs) that complex with intracellularly expressed Cas9 and target the gene exon of interest to generate random indels (in essence, gene knockouts). We used this method here to determine the functional role of <italic>MTIF3</italic> in adipocyte biology.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The workflow of establishing hWAs-iCas9 cell line and its application in studying MTIF3 and environment interactions in vitro.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig2-v2.tif"/></fig></sec><sec id="s2-3"><title>Generation of <italic>MTIF3</italic> knockout in hWAs-iCas9 mature adipocytes</title><p>To investigate the role of <italic>MTIF3</italic> in human adipocyte development and energy metabolism we generated stable <italic>MTIF3</italic> knockouts in differentiated hWAs-iCas9 adipocytes. We designed Cas9-specific sgRNA to generate random indels in the exon expressed in all three <italic>MTIF3</italic> protein-encoding transcripts (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and obtained a &gt;80% reduction in MTIF3 protein levels in every experiment, as assessed by western blotting (<xref ref-type="fig" rid="fig3">Figure 3B–D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, and <xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). To assess off-target effects of CRISPR-Cas9, we also performed T7EI assays on PCR-amplified top 5 predicted off-target sites and did not observe any detectable off-targeting (data are not shown).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>MTIF3 perturbation in mature adipocytes does not affect adipocyte-specific protein expression or total triglyceride content.</title><p>(<bold>A</bold>) An illustration of Cas9-specific single guide RNA (sgRNA)-binding site in the exon expressed in all three <italic>MTIF3</italic> protein-encoding transcripts. (<bold>B</bold>) Representative Sanger sequencing of control and knockout hWAs mature adipocytes. (<bold>C</bold>) Immunoblots of adipocyte markers in scrambled control and <italic>MTIF3</italic> knockout adipocytes, <italic>n</italic> = 5 independent experiments. (<bold>D</bold>) Quantitative analysis of MTIF3 band densities in (<bold>C). (E</bold>) Quantitative analysis of ACC, FABP4, and FAS band densities in (<bold>C). (F</bold>) Representative Oil-red O staining images of control and MTIF3 knockout in hWAs mature adipocytes. Scale bar is 200 µm. (<bold>G</bold>) Total triglyceride content in scrambled control (SC) and <italic>MTIF3</italic> knockout (KO) cells. n = 3 independent experiments. Error bars show standard deviation in all plots. Statistical analysis was performed using two-tailed Student’s <italic>t</italic>-test, p values are presented in each graph. Uncropped blot images for (<bold>C</bold>) and raw.scn data files can be found in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw data files for western blots shown in <xref ref-type="fig" rid="fig3">Figure 3C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84168-fig3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>To test the effects of <italic>MTIF3</italic> knockout on adipogenic differentiation in hWAs-iCas9 cell line, we first induced <italic>MTIF3</italic> knockout in hWAs-iCas9 pre-adipocytes, then differentiated them using standard adipogenic differentiation cocktail.</title><p>After 12 days of differentiation, we assessed <italic>MTIF3</italic> knockout efficiency using western blots, and examined adipogenic marker gene expression by RT-qPCR. <italic>MTIF3</italic> expression was efficiently decreased in the knockout cells in <italic>n</italic> = 6 independent experiments (panels <bold>A, B</bold>). There were no significant differences between scrambled control and <italic>MTIF3</italic> knockout cells on adipogenesis markers <italic>PPARG</italic>, <italic>ADIPOQ</italic>, <italic>CEBPA</italic>, <italic>SREBF1</italic>, and <italic>FABP4</italic> expression (panel <bold>C</bold>); <italic>n</italic> = 5 independent experiments. Error bars show standard deviation. Statistical analyses were performed using paired Student’s <italic>t</italic>-test, and p values are presented in the graphs. Uncropped blot images for panel A and raw.scn data files can be found in <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Raw data files for western blots shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84168-fig3-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig3-figsupp1-v2.tif"/></fig></fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>MTIF3 perturbation in mature adipocytes disrupts mitochondrial gene expression and OXPHOS complex assembly.</title><p>(<bold>A</bold>) Immunoblots of mitochondrial genome-encoded proteins in scrambled control and <italic>MTIF3</italic> knockout adipocytes. (<bold>B</bold>) Quantitative analysis of band densities in (<bold>A). (C</bold>) qPCR for mitochondrial gene expression in scrambled control and <italic>MTIF3</italic> knockout adipocytes, <italic>n</italic> = 5 independent experiments. (<bold>D</bold>) Relative mitochondrial DNA content in scrambled control and <italic>MTIF3</italic> knockout adipocytes, <italic>n</italic> = 5 independent experiments. (<bold>E</bold>) Immunoblots of mitochondrial OXPHOS complex assembly after Blue Native-PAGE electrophoresis, <italic>n</italic> = 4 independent experiments. (<bold>F</bold>) Quantitative analysis of band densities in (<bold>E</bold>). Error bars show standard deviation in all plots. Statistical analysis was performed using two-tailed Student’s <italic>t</italic>-test, p values are presented in each graph. Uncropped blot images for (<bold>A</bold>) and raw.scn data files can be found in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>. Uncropped blot images for (<bold>E</bold>) and raw.scn data files can be found in <xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref>.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw data files for western blots shown in <xref ref-type="fig" rid="fig4">Figure 4A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84168-fig4-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Raw data files for western blots shown in <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84168-fig4-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig4-v2.tif"/></fig></sec><sec id="s2-4"><title><italic>MTIF3</italic> knockout in mature adipocytes does not affect adipogenic marker or lipid content</title><p>Although the <italic>MTIF3</italic> knockout in hWAs-iCas9 cells was generated <italic>after</italic> the cells were differentiated, we wanted to ensure the genetic perturbation did not affect adipogenic markers or triglyceride content, as that could confound results from downstream functional studies. Incidentally, we observed that the quantities of the adipogenic markers, including ACC, FABP4, and FAS were comparable in control and <italic>MTIF3</italic> knockout cells (<xref ref-type="fig" rid="fig3">Figure 3C, E</xref>; see also <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Similarly, there were no apparent differences in Oil-red O or total triglyceride content (<xref ref-type="fig" rid="fig3">Figure 3F, G</xref>).</p></sec><sec id="s2-5"><title><italic>MTIF3</italic> knockout disrupts mitochondrial DNA-encoding gene and protein expression, mitochondrial content, as well as mitochondrial OXPHOS assembly in hWAs-iCas9 adipocytes</title><p>MTIF3 is a mitochondrial translation initiation factor; thus, we examined the effects of MTIF3 ablation on differentiated hWAs adipocyte mitochondrial respiration chain. Assessed by western blotting, the <italic>MTIF3</italic> knockout cells had significantly decreased COX II (subunit of OXPHOS complex IV) and ND2 (subunit of OXPHOS complex I), trending decrease of CYTB (subunit of OXPHOS complex III), and unchanged ATP8 (subunit of OXPHOS complex V) content (<xref ref-type="fig" rid="fig4">Figure 4A , B</xref>). Moreover, using qPCR, we observed an altered expression of several mitochondrial DNA-encoding genes. Specifically, MTIF3 deficiency led to higher expression of <italic>MT-ND1</italic>, <italic>MT-ND2</italic>, a trending increase of <italic>MT-ND4</italic>, and lower expression of <italic>MT-ND3</italic>, and <italic>MT-CO3</italic> (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In addition, we also found significantly reduced mitochondrial content in <italic>MTIF3</italic> knockout adipocytes (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Taken together, the above data suggest <italic>MTIF3</italic> knockout disrupts mitochondrial DNA-encoding gene and protein expression.</p><p>Next, we hypothesized the above observations could have originated from the insufficient MTIF3 supply during OXPHOS complex assembly (a role previously ascribed to MTIF3 [<xref ref-type="bibr" rid="bib34">Rudler et al., 2019</xref>]). To test this, we used Blue Native-PAGE to examine OXPHOS complexes in mitochondria isolated from <italic>MTIF3</italic> knockout adipocytes. MTIF3 deficiency led to decreased complex III<sub>2</sub>/IV<sub>2</sub> and IV<sub>1</sub>, and a trending decreased complex V/III<sub>2</sub> + IV<sub>1</sub> assembly. In contrast, OXPHOS complex II assembly was significantly increased in <italic>MTIF3</italic> knockout cells (<xref ref-type="fig" rid="fig4">Figure 4E, F</xref>). Interestingly, we also observed faster-migrating undefined bands in <italic>MTIF3</italic> knockout adipocytes (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), which could be single chain proteins, or mistranslation or degradation products. Lastly, The OXPHOS complex I + III<sub>2</sub> + IV<sub><italic>n</italic></sub> appeared to be less abundant in <italic>MTIF3</italic> knockout mitochondria, although the bands appeared more diffuse and could not be quantified (<xref ref-type="fig" rid="fig4">Figure 4E</xref>).</p></sec><sec id="s2-6"><title><italic>MTIF3</italic> knockout affects mitochondrial respiration in hWAs-iCas9 adipocytes</title><p>Having established the role of MTIF3 in adipocyte mitochondria OXPHOS complex assembly, and in mitochondrial gene expression, we then investigated the mitochondrial function in MTIF3-ablated differentiated hWAs adipocytes using Seahorse Mito Stress Test. Additionally, to avoid potential cofounders caused by the high glucose content in the differentiation medium, we adapted the cells to 1 g/l glucose growth medium for 3 days before running the assay. As shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>, <italic>MTIF3</italic> knockout cells exhibited lower basal oxygen consumption rate (OCR), as well as lower ATP-forming capacity, the latter estimated by calculating OCR decrease after blocking ATP synthase with oligomycin (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). <italic>MTIF3</italic> knockout cells also showed a trending decrease in maximal respiration OCR (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Furthermore, both <italic>MTIF3</italic> knockout and control cells, had comparable proton leak OCR, non-mitochondrial respiration OCR and coupling efficiency (<xref ref-type="fig" rid="fig5">Figure 5E–G</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Cellular mitochondrial respiration in hWAs adipocytes.</title><p>(<bold>A</bold>) The average oxygen consumption rate (OCR) traces during basal respiration, and after addition of oligomycin, FCCP, and rotenone/antimycin A. (<bold>B</bold>) Basal respiration OCR, <italic>n</italic> = 4 different cell passages. (<bold>C</bold>) ATP production OCR, <italic>n</italic> = 4 different cell passages. (<bold>D</bold>) Maximal respiration OCR, <italic>n</italic> = 4 different cell passages. (<bold>E</bold>) Proton leak OCR, n = 4 different cell passages. (<bold>F</bold>) Non-mitochondrial respiration OCR, n = 4 different cell passages. (<bold>G</bold>) Coupling efficiency, <italic>n</italic> = 4 different cell passages. Error bars show standard deviation. Statistical analyses were performed using paired Student’s <italic>t</italic>-test in each condition, p values are presented in each graph.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig5-v2.tif"/></fig></sec><sec id="s2-7"><title><italic>MTIF3</italic> knockout affects hWAs-iCas9 adipocyte endogenous fatty acid oxidation</title><p>Next, we used Seahorse to assess the endogenous fatty acid oxidation in <italic>MTIF3</italic> knockout versus control cells treated with etomoxir (an inhibitor of carnitine palmitoyl transferase). We found that MTIF3 ablation mimics the effect of etomoxir on basal endogenous fatty acid oxidation OCR. Furthermore, while etomoxir decreases basal fatty acid oxidation OCR in control cells, it does not markedly decrease it in <italic>MTIF3</italic> knockout cells (<xref ref-type="fig" rid="fig6">Figure 6A, B</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>MTIF3 perturbation affects adipocyte fatty acid oxidation.</title><p>(<bold>A</bold>) A representative Seahorse oxygen consumption rate (OCR) trace for endogenous fatty acid oxidation assay. <italic>MTIF3</italic> knockout and scrambled control adipocytes were treated with or without etomoxir for 15 min before the assay. Following the basal OCR measurement, oligomycin, FCCP (carbonyl cyanide-<italic>p</italic>-trifluoromethoxyphenylhydrazone), and rotenone + antimycin A were added sequentially to measure the detection of ATP production OCR, maximal respiration OCR and non-mitochondrial respiration OCR. (<bold>B</bold>) Basal endogenous fatty acid oxidation OCR in scrambled control (SC) and <italic>MTIF3</italic> knockout (KO) adipocytes, <italic>n</italic> = 4 independent experiments. (<bold>C</bold>) Upper panel: workflow of glucose restriction in differentiated adipocytes; Lower left panel: total triglyceride content in scrambled control (SC) and <italic>MTIF3</italic> knockout (KO) adipocytes in 25 mM glucose conditions; Lower right panel: triglyceride content in adipocytes cultured in glucose-restricted conditions (5, 3, and 1 mM) relative to adipocytes cultured in 25 mM glucose, <italic>n</italic> = 4 independent experiments. (<bold>D</bold>) <italic>Z</italic>-score-normalized data for glycerol release in scrambled control and <italic>MTIF3</italic> knockout adipocytes under basal, insulin-stimulated, and isoproterenol-stimulated conditions, <italic>n</italic> = 4 independent experiments. (<bold>E</bold>) qPCR for mitochondrial and adipocyte-related gene expression in scrambled control and <italic>MTIF3</italic> knockout adipocytes. Error bars show standard deviation in all plots. Statistical analysis was performed using two-tailed Student’s <italic>t</italic>-test, p values are presented in each graph.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title><italic>MTIF3</italic> knockout does not affect mature adipocyte glycerol release at either 25 or 1 mM glucose condition.</title><p>To assay this, we incubated the differentiated adipocytes in glycerol release assay medium supplemented with either 25 or 1 mM glucose. We then determined glycerol content in each sample after 2-hr incubation. We found no differences in glycerol release between scrambled control and <italic>MTIF3</italic> knockout cells cultured in the same glucose concentration. Notably, both scrambled control and <italic>MTIF3</italic> knockout cells had significantly decreased glycerol release in 1 mM glucose restriction condition. <italic>n</italic> = 3 independent experiments, with 3 replicates per group and experiment. Error bars show standard deviation. Statistical analyses were performed using paired Student’s <italic>t</italic>-test, and p values are presented in the graph.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig6-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-8"><title><italic>MTIF3</italic> knockout affects hWAs-iCas9 adipocyte triglyceride content after glucose restriction challenge</title><p>To mimic the interactions between MTIF3 content and dietary intervention on weight change, we generated hypertrophic control and <italic>MTIF3</italic> knockout hWAs-iCas9 adipocytes and then used glucose-limited medium, not supplemented with free fatty acids (FFAs), to mimic energy restriction in vivo (schematic shown in <xref ref-type="fig" rid="fig6">Figure 6C</xref>). Triglyceride content decreased both in control and <italic>MTIF3</italic> knockout cells after 3 days of different levels of glucose restriction when compared with 25 mM glucose medium. Interestingly, a more extensive decrease in triglyceride content occurred in control cells cultured in 1 mM glucose medium (p = 0.053), and a similar trending decrease, albeit with higher coefficient of variation, occurred in 3 and 5 mM glucose medium (<xref ref-type="fig" rid="fig6">Figure 6C</xref>).</p></sec><sec id="s2-9"><title><italic>MTIF3</italic> knockout does not affect lipolysis-mediated glycerol release in hWAs adipocytes</title><p>Owing to the effects of MTIF3 ablation on triglyceride content and on fatty acid oxidation, described above, we then examined the effects of <italic>MTIF3</italic> knockout on lipolysis. We measured basal, insulin-attenuated, and isoproterenol-stimulated glycerol release in differentiated hWAs cells. As shown in <xref ref-type="fig" rid="fig6">Figure 6D</xref>, in all three conditions, glycerol release in control and <italic>MTIF3</italic> knockout cells was comparable. In addition, basal glycerol release in glucose-restricted conditions was similar (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), and significantly reduced in low glucose versus high glucose assay medium.</p></sec><sec id="s2-10"><title><italic>MTIF3</italic> knockout affects mitochondrial function- and fatty acid oxidation-related gene expression</title><p>Next, we examined how MTIF3 ablation affects the gene expression programmes pertinent to mitochondrial function, fatty acid oxidation, lipolysis and lipid catabolism. As shown in <xref ref-type="fig" rid="fig6">Figure 6E</xref>, <italic>MTIF3</italic> knockout cells had decreased expression of the mitochondria-related <italic>MT-CO1</italic>, and the fatty acid oxidation-related <italic>ACADM</italic> and <italic>ACAT1</italic>, but unchanged expression of other genes involved in mitochondrial function and lipid metabolism (<italic>TFAM</italic>, <italic>TOMM20</italic>, <italic>PRDM16</italic>, <italic>CPT1B</italic>, <italic>ABHD5</italic>, <italic>PNPLA2</italic>, and <italic>ACACB</italic>).</p></sec><sec id="s2-11"><title><italic>MTIF3</italic> knockout results in glucose level-depending alterations in metabolism</title><p>Considering the observed effect of MTIF3 ablation on mitochondrial function and fatty acid oxidation, we assessed the metabolite profile in <italic>MTIF3</italic> knockout cells. Using combined GC/MS and LC/MS metabolite profiling resulted in relative quantification of 110 metabolites. First, we analyzed metabolite profiles at a global level using PCA. The score plot reveals a clear systematic difference in the metabolite profile between cells in 25 mM glucose versus in glucose restriction (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Interestingly, differences between <italic>MTIF3</italic> knockout and control cells at 25 mM glucose are observed along principal component 1 (PC1), whereas differences between genotypes at glucose restriction are observed along PC2, suggesting the effect of MTIF3 ablation to depend on the calorie level. Next, to identify alterations in metabolite levels underlying this differential response, we analyzed data using orthogonal projections to latent structures discriminant analysis (OPLS-DA) separately at 25 mM glucose condition (two components <italic>R</italic>2 = 0.82, <italic>Q</italic>2 = 0.66) and at glucose restriction (two components, <italic>R</italic>2 = 0.95, <italic>Q</italic>2 = 0.52). These analyses revealed systematic differences between genotypes at both growth conditions (<xref ref-type="fig" rid="fig7">Figure 7 B, C</xref>). Next, to examine whether the differences between genotype depended on growth condition, we combined the correlations from the two OPLS-DA models into a shared and unique structures plot (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). These analyses revealed levels of intermediates in cytosolic metabolic pathways connected to the glycolysis, such as glycerate 3-phosphate, glycerol 2-phosphate, UDP-<italic>N</italic>-acetylglucosamine, and ribose 5-phosphate, to be lower in <italic>MTIF3</italic> knockout cells at both glucose concentrations. Interestingly, levels of fatty acids, ranging from 9 to 17 carbons and including several odd-chain fatty acids, were lower in the <italic>MTIF3</italic> knockout cells only at 25 mM glucose condition. At glucose-restricted conditions, levels of both essential and non-essential amino acids were lower in the knockout. Finally, we analyzed data using two-way analysis of variance (ANOVA), incorporating glucose concentration and genotype, thereby providing information on effects at the individual metabolite level. These analyses revealed 18 and 20 significantly different metabolites between control and <italic>MTIF3</italic> knockout cells at 25 mM glucose condition and glucose-restricted conditions, respectively (<italic>q</italic> &lt;0.05). These included ribose 5-phosphate, glycerate 3-phosphate, glycerol 2-phosphate, and glycerol 3-phosphate (<xref ref-type="fig" rid="fig7">Figure 7E</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Mass spectrometry-based metabolomics data for control (SC) and <italic>MTIF3</italic> knockout (KO) cells in 25 mM glucose (NF, normal feeding) and 5 mM glucose (GR, glucose-restricted) conditions.</title><p>(<bold>A</bold>) Principal component analysis (PCA) score plot displaying the discrimination between <italic>MTIF3</italic> knockout and control cells in normal and glucose-restricted conditions (PC1: 28%, PC2: 19%). (<bold>B</bold>) Orthogonal projections to latent structures discriminant analysis (OPLS-DA) score plot showing classification of <italic>MTIF3</italic> knockout and control cells in 25 mM glucose condition. (<bold>C</bold>) OPLS-DA score plots showing classification of <italic>MTIF3</italic> knockout and control cells in glucose-restricted condition. (<bold>D</bold>) Shared and unique structures (SUS) plot, based on OPLS-DA models in (<bold>B, C</bold>), showing glucose concentration-dependent differences between <italic>MTIF3</italic> knockout and control cells. (<bold>E</bold>) Box plots showing the abundance of some of the significantly altered metabolites in normal and <italic>MTIF3</italic> knockout cells in normal and glucose-restricted conditions. Statistical analysis was performed using two-way analysis of variance (ANOVA) test, p values are presented in each graph.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84168-fig7-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Excessive weight gain caused by dietary excess, and its effects on adipocyte lipid metabolism, can cause life-threatening disease (<xref ref-type="bibr" rid="bib3">Appleton et al., 2013</xref>; <xref ref-type="bibr" rid="bib12">Denis and Obin, 2013</xref>; <xref ref-type="bibr" rid="bib9">Chu et al., 2017</xref>; <xref ref-type="bibr" rid="bib24">Lotta et al., 2018</xref>). Findings from clinical trials (<xref ref-type="bibr" rid="bib29">Papandonatos et al., 2015</xref>), a bariatric surgery case series (<xref ref-type="bibr" rid="bib33">Rasmussen-Torvik et al., 2015</xref>) and epidemiological cohorts (<xref ref-type="bibr" rid="bib28">Nettleton et al., 2015</xref>) showed the <italic>MTIF3</italic> variation modulates weight loss-promoting exposures on body weight (see also UK Biobank analysis in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Here, we validated <italic>MTIF3</italic> rs1885988 C allele correlates with higher <italic>MTIF3</italic> expression in subcutaneous fat tissue, and our in vitro luciferase reporter assay and CRISPR-Cas9 genome editing results revealed that the tightly linked rs67785913 variant is likely to be the actual eQTL for <italic>MTIF3</italic> expression (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Pre-adipocyte cell lines have been used extensively for studying adipogenic differentiation (<xref ref-type="bibr" rid="bib35">Ruiz-Ojeda et al., 2016</xref>), but their application for lipid metabolism studies has been limited, especially in the context of gene–environment interaction. This is largely due to the variation of differentiation capacity across cell passages (<xref ref-type="bibr" rid="bib32">Poulos et al., 2010</xref>) and differential genetic effects on adipocyte differentiation (<xref ref-type="bibr" rid="bib20">Kamble et al., 2020</xref>), which can alter baseline phenotypes in differentiated cells. Therefore, we established an inducible Cas9-expressing human pre-adipocyte cell line (hWAs-iCas9), which enabled us to generate gene knockout of interest in differentiated adipocytes, thus circumventing these limitations (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Using the inducible knockout cell model, we then tested interactions between <italic>MTIF3</italic> and environmental changes (lifestyle mimetics). Our data reveal that <italic>MTIF3</italic> deficiency mediated disrupted mitochondrial respiration, probably as a consequence of decreased OXPHOS complex assembly. This led to perturbed cellular functions, including reduced fatty acid oxidation and a trending increase in intracellular triglyceride content. These data indicate that <italic>MTIF3</italic> plays an important role in lipid metabolism in human adipocytes.</p><p>In adipose tissue, mitochondria play an essential role not only by ensuring ATP supply but also by triggering cellular signaling pathways that require reactive oxygen species generated by OXPHOS complexes I and III (<xref ref-type="bibr" rid="bib41">Tormos et al., 2011</xref>). These, and complexes IV and V, are partially encoded by mitochondrial DNA (<xref ref-type="bibr" rid="bib25">Maechler and Wollheim, 2001</xref>). The post-transcriptional rate-limiting translation step can be promoted by MTIF3, as it facilitates initiation complex formation on mitochondrial 55S ribosomes in the presence of MTIF2, fMet-tRNA, and poly(A,U,G) (<xref ref-type="bibr" rid="bib5">Bhargava and Spremulli, 2005</xref>). Previous studies have shown that loss of MTIF3 results in an imbalanced assembly of OXPHOS complexes in muscle and heart in mouse (<xref ref-type="bibr" rid="bib34">Rudler et al., 2019</xref>) and decreased translation of ATP6 mRNA in hepatocyte-like HepG2 cells (<xref ref-type="bibr" rid="bib8">Chicherin et al., 2020</xref>). Our data show that in adipocytes MTIF3 deficiency results in lower content of mitochondrial DNA-encoding proteins and altered expression of several mitochondrial DNA-encoding genes. Furthermore, it leads to disassembly of mitochondrial respiration OXPHOS complex, along with impaired mitochondrial respiration rate (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>). Altogether, our results suggest that MTIF3 vastly affects the mitochondrial electron transport chain.</p><p>Mitochondrial dysfunction in white adipose tissue has been frequently associated with obesity (<xref ref-type="bibr" rid="bib19">Kaaman et al., 2007</xref>), with the presumed mechanisms being decreased fatty acid oxidation and ATP production (reviewed in <xref ref-type="bibr" rid="bib17">Heinonen et al., 2020</xref>). We have found that one causal link connecting these factors may be the MTIF3 content (<xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>). Furthermore, a previous study described an inverse relationship between mitochondrial capacity and weight change (<xref ref-type="bibr" rid="bib18">Jokinen et al., 2018</xref>); thus, conceivably, any genetic variation-modulated change in <italic>MTIF3</italic> expression could influence a dietary intervention outcome. We attempted to test this hypothesis in vitro, exposing hypertrophic adipocytes to glucose restriction, thereby mimicking weight loss-promoting exposures in vivo. We found that MTIF3-deficient adipocytes exposed to glucose restriction challenge responded less through changed triglyceride content, indicating limited capacity for lipid metabolism under glucose restriction (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Intriguingly, we did not observe altered lipolysis (glycerol release) in <italic>MTIF3</italic> knockouts, either in the presence or absence of insulin and isoproterenol, or during glucose restriction. Here, we speculate that <italic>MTIF3</italic> knockouts, having reduced fatty acid oxidation, re-esterify the released fatty acids to triglycerides, and thus retain more triglycerides during glucose restriction.</p><p>Mitochondrial function is robustly associated with insulin sensitivity (<xref ref-type="bibr" rid="bib6">Böhm et al., 2020</xref>; <xref ref-type="bibr" rid="bib31">Pietiläinen et al., 2008</xref>; <xref ref-type="bibr" rid="bib16">Heinonen et al., 2015</xref>), both of which can be improved through lifestyle intervention aiming at weight loss (<xref ref-type="bibr" rid="bib30">Phielix et al., 2010</xref>; <xref ref-type="bibr" rid="bib40">Toledo et al., 2007</xref>; <xref ref-type="bibr" rid="bib22">Larson-Meyer et al., 2006</xref>; <xref ref-type="bibr" rid="bib10">Civitarese et al., 2007</xref>). Furthermore, impaired adipocyte differentiation derived from mitochondrial dysfunction in adipose tissue often associates with insulin resistance in humans and animal models (<xref ref-type="bibr" rid="bib36">Sakers et al., 2022</xref>; <xref ref-type="bibr" rid="bib46">Zhu et al., 2022</xref>). In our study, we did not observe impaired adipocyte differentiation due to MTIF3 deficiency or rs67785913 eQTL. These results, however, may not be directly translatable to in vivo conditions, in part because in vitro differentiation protocols employ relatively highly concentrated adipogenic compounds. Further in vivo studies are therefore needed to establish any link between MTIF3 content and insulin resistance. Similarly, long-term in vivo studies on the effect of altered <italic>MTIF3</italic> expression on body weight are warranted to illuminate the translatability of the short-term or low effect size in vitro experiments (e.g., <xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>). We envisage that the MTIF3 effect on adipocyte metabolism, while not dramatic in some of the presented data, could translate into larger effect size over time in vivo. Here, MTIF3 effect on metabolism in other tissues (e.g., muscle) would further contribute to body weight regulation. Lastly, one should bear in mind that our in vitro data were generated in cells highly depleted of MTIF3, and the extent to which a more moderate MTIF3 deficiency in vivo (e.g., conferred by common genetic variants) influences adipogenic differentiation or long-term diet-induced weight loss is currently unknown.</p><p>Finally, the metabolomic analysis added another dimension to the role of MTIF3 in regulating adipocyte metabolism (<xref ref-type="fig" rid="fig7">Figure 7</xref>). The lower content of glycolysis intermediates and odd-chain fatty acids in <italic>MTIF3</italic> knockout adipocytes could indicate blunted lipogenesis, while the decreased essential and non-essential amino acid level in <italic>MTIF3</italic> knockout cells under glucose restriction could be an adaption to the lower energy supply owing to impaired mitochondrial function (<xref ref-type="bibr" rid="bib15">Hansson et al., 2004</xref>). The metabolite data, and the earlier described lower fatty acid oxidation capacity of MTIF3-deficient cells, suggest that MTIF3 plays a vital role in triglyceride metabolism in adipocytes, and provides further insight into the previously reported role of this protein on weight loss induced by dietary intervention (<xref ref-type="bibr" rid="bib29">Papandonatos et al., 2015</xref>).</p><p>In summary, we experimentally demonstrated that the common genetic variant rs67785913 is a functional polymorphism that causes modulated <italic>MTIF3</italic> expression. Our functional genomics studies demonstrate that MTIF3 is essential for mitochondrial electron transport chain complex assembly, mitochondrial function, and lipid metabolism in human adipocyte cell lines. MTIF3 content may also influence adipocyte triglyceride content in conditions that mimic dietary restriction, reflecting a gene x environment interaction. Since our findings show that higher <italic>MTIF3</italic> content in adipocytes increases mitochondrial function, this helps explain the previously observed interaction between <italic>MTIF3</italic> locus and weight loss interventions. Furthermore, this suggests, although it remains to be demonstrated, that people who carry genetic variants that increase <italic>MTIF3</italic> expression (e.g., the rs67785913 CTCT allele) may benefit more from lifestyle interventions targeting weight loss.</p><p>Lastly, we established a novel, efficient, and simple method to generate gene knockouts in differentiated adipocyte cell lines, and the method should be suitable for generating other gene knockouts.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Allele-specific <italic>MTIF3</italic> expression in subcutaneous adipose tissue</title><p>Data and plots presented in this manuscript for allele-specific <italic>MTIF3</italic> expression in subcutaneous adipose tissue were obtained from GTEx Portal (<ext-link ext-link-type="uri" xlink:href="https://www.gtexportal.org/home/">https://www.gtexportal.org/home/</ext-link>) on 10/5/2022.</p></sec><sec id="s4-2"><title>Cell culture</title><p>A human white pre-adipocyte cell line (hWAs) was previously isolated and immortalized from human subcutaneous white adipose tissue of a female subject, aged 56 with a BMI of 30.8. The generation and characterization of hWAs were described previously (<xref ref-type="bibr" rid="bib45">Xue et al., 2015</xref>), and the cell line was kindly shared by Professor Yu-Hua Tseng (Joslin Diabetes Center, Harvard Medical School, USA). hWAS cells. For expansion, cells were cultured in 25 mM Dulbecco’s Modified Eagle Medium (DMEM) with GlutaMAX (10566016, Thermo Fisher Scientific), 10% fetal bovine serum (FBS; HyClone, GE Healthcare, Uppsala, Sweden), and 1% (100 U/ml) penicillin/streptomycin (15140122, Thermo Fisher Scientific). The cells were passaged at 90% confluence, and tested negative for mycoplasma.</p></sec><sec id="s4-3"><title>DNA isolation and luciferase reporter assays</title><p>Genomic DNA was isolated from hWAs cells using DNeasy Blood and Tissue kit (69506, QIAGEN) according to the manufacturer’s manual. To fine map the transcriptional regulatory regions in the <italic>MTIF3</italic> locus, we first identified the common genetic variants which were in tight linkage disequilibrium (<italic>r</italic><sup>2</sup> ≥ 0.8) with the lead variant rs1885988 in HaploReg v4.1 (<xref ref-type="bibr" rid="bib43">Ward and Kellis, 2012</xref>). The thus identified 31 SNPs were tiled down into 12 DNA segments of the <italic>MTIF3</italic> gene, as shown in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>. These segments were then PCR amplified from hWAs DNA, all ranging from 700 to 1600 bp in size (depending on PCR primer design constraints), and with all SNP loci located several hundred bp from the ends of each fragment. The PCR primers were also designed to include flanking KpnI and EcoRV sites to allow cloning into the pGL4.23 minimal promoter luc2 luciferase reporter vector (Promega). For the reporter assays, hWAs were seeded into 96-well plates, and on the following day transfected with 95 ng of the pGL4.23 vectors and 5 ng pGL4.75 CMV-Renilla reporter vectors (for normalization), using Lipofectamine 3000 (Thermo Fisher Scientific), in technical duplicates. Two days after transfection, the luc2 and Renilla signals were detected using Dual-Glo Stop&amp;Glo reagents (E2920, Promega). The averages of technical duplicates were used to calculate luc2:Renilla ratios, which were then <italic>Z</italic>-score normalized to allow statistical evaluation across four independent experiments.</p></sec><sec id="s4-4"><title>gRNAs and ssDNA design for CRISPR/Cas9 mediated editing of rs67785913 in hWAs cells</title><p>To edit the rs67785913 CT allele to the minor CTCT allele in hWAs cell genome, CRISPR/Cas9 D10A nickase (Alt-R S.p. Cas9 D10A Nickase V3, IDT) and two sgRNAs, and an ssDNA donor template were used. The sgRNA spacer sequences were: 5′-<named-content content-type="sequence">TTCAATAAGAAATTCCTCAA</named-content>-3′ and 5′-<named-content content-type="sequence">GAAGAAAAAGGGGGGACACG</named-content>-3′. The ssDNA sequence was 5′-<named-content content-type="sequence">TGTGGACTCGCAGTCTGCCCTTGAGGAATTTCTTATTGAAGAAGAAAAAGAGGGGGGACACGGGGCCCAGACCCCCAGCACCCGGCTTTCGAGCAGGCTC</named-content>-3′. All oligonucleotides, sgRNAs, and ssDNA were purchased from Integrated DNA Technologies. The transfection was performed using Nucleofector 2b device (program A-033) (Lonza, Sweden) in nucleofector reagent L (Lonza, Sweden) mixed with 5 × 10<sup>5</sup> hWAs cells, 120 pmol Cas9 nickase, 104 pmol sgRNA, and 300 pmol ssDNA. To increase the homology directed repair (HDR) editing efficiency, cells were incubated at 32°C for 2 days in growth medium containing 30 μM HDR enhancer (Alt-R HDR Enhancer V2, IDT). Subsequently, cells were transferred to 37°C for 3 days. For single-cell cloning, the hWAs cells were seeded at low density (2 cells/well in a 96-well plate) and allowed to expand for 3 weeks. Then the genomic DNA was extracted using QuickExtract DNA Extraction Solution (Lucigen) from the apparent single-cell clonal populations. To identify the allele-edited homozygous clones, PCR was used to amplify the DNA fragment surrounding rs67785913 using primer pairs as below: Forward 5′–3′ <named-content content-type="sequence">GATTTGCAGGTGAGCAGACA</named-content>, Reverse 5′–3′ <named-content content-type="sequence">ACTTGGAAATGGCCAAGATG</named-content>; the amplicon was then subjected to Sanger sequencing to confirm the DNA sequence of each clone.</p></sec><sec id="s4-5"><title>Generation of inducible CRISPR/Cas9-expressing hWAs cell line (hWAs-iCas9)</title><p>hWAs cells were first seeded at 80,000 cells/well in 6-well plates and transfected with 200 ng Super PiggyBac transposase (PB210PA-1, System Biosciences) and 500 ng pPB-rtTA-hCas9-puro-PB plasmid (kind gift from Dr. William Pu) (<xref ref-type="bibr" rid="bib42">Wang et al., 2017</xref>) using Lipofectamine 3000 (Thermo Fisher Scientific). The plasmid carries a doxycycline-inducible promoter driving the expression of Cas9, and a puromycin resistance gene, all flanked by piggyBac transposon integration sequences. After 2 days, the transfected cells were selected and expanded for 3 weeks in growth medium with 1 μg/ml puromycin, to obtain cells with genomically integrated inducible Cas9 construct.</p></sec><sec id="s4-6"><title>Differentiation of hWAs-iCas9 pre-adipocytes into mature adipocytes</title><p>hWAs-iCas9 pre-adipocytes were seeded into 24- or 96-well plates at the density of 40,000 or 8000 cells/well, respectively. After 3 days, the cells reached confluency and were then incubated for 12 days with the differentiation cocktail, with medium changes every 3 days, as described before (<xref ref-type="bibr" rid="bib37">Shamsi and Tseng, 2017</xref>). To increase the accumulation of lipid droplets, 30 μM FFA (Linoleic Acid-Oleic Acid-Albumin) (L9655, Sigma-Aldrich) was added to the differentiation medium (<xref ref-type="bibr" rid="bib4">Aprile et al., 2020</xref>).</p></sec><sec id="s4-7"><title>CRISPR/Cas9 guide RNA design and off-targeting check</title><p>To generate <italic>MTIF3</italic> knockout adipocytes, guide RNA spacer sequence targeting <italic>MTIF3</italic> exon 5, expressed in all known <italic>MTIF3</italic> protein-encoding transcripts (as reported at <ext-link ext-link-type="uri" xlink:href="https://www.ensembl.org">https://www.ensembl.org</ext-link>), was selected. The spacer sequence was <named-content content-type="sequence">5′-GCAATAGGGGACAACTGTGC-3′</named-content>, and full-length sgRNA was purchased from IDT. Furthermore, the hWAs genomic sequence surrounding the gRNA-binding site was amplified by PCR using the primers <named-content content-type="sequence">5′-CCACTTGTCTTGGGGACAGT-3′</named-content> and <named-content content-type="sequence">5′-CTGGGAATGGTGGTTGAATC-3′</named-content>, then analyzed by Sanger sequencing to ensure sequence match between gRNA spacer and the intended target locus. The potential off-target sites were predicted using CRISPR-Cas9 guide RNA design checker (<ext-link ext-link-type="uri" xlink:href="https://eu.idtdna.com">https://eu.idtdna.com</ext-link>), and the genomic regions surrounding the top 5 off-target sites were PCR amplified from the genomic DNA extracted from <italic>MTIF3</italic>-knockout and scramble control cells. The amplicons were then analyzed for any heteroduplexes generated by off-targeting using T7EI assay (IDT, Alt-R Genome Editing Detection Kit).</p></sec><sec id="s4-8"><title>sgRNA transfection and <italic>MTIF3</italic> knockout in mature adipocytes</title><p>After 12 days of differentiation, Cas9 expression was induced in mature adipocytes by adding 2 μg/ml doxycycline to the growth medium. On the following day, 30 nM pre-designed sgRNA was delivered into the cells using Lipofectamine RNAiMAX (13778075, Thermo Fisher Scientific) according to the manufacturer’s protocol; in parallel, 30 nM negative control crRNA (1072544, IDT) was used to transfect the scrambled control cells. One day post-transfection, cells were washed with phosphate-buffered saline (PBS) and incubated in normal growth medium for at least 3 days before functional assays carried out.</p></sec><sec id="s4-9"><title>Oil-red O staining</title><p>After MTIF3 knockout, the differentiated white adipocytes were washed twice with PBS and fixed for 10–20 min with 4% buffered formalin at room temperature. The cells were then stained with Oil-red O solution for 30 min at room temperature, followed by five washes with distilled water. The stained cells were visualized using light microscopy.</p></sec><sec id="s4-10"><title>Glucose restriction challenge for hWAs-iCas9 adipocytes</title><p>The hWAs-iCas9 adipocytes were firstly differentiated to mature adipocytes as described above (in FFA-supplemented medium), then the <italic>MTIF3</italic> knockouts and scrambled controls were generated, also as described above. After 3 days, the mature adipocytes were incubated in DMEM medium (11966025, Thermo Fisher Scientific) without FFA, and supplemented with different glucose concentrations (5, 3, and 1 mM) for the glucose restriction test. The cells were then incubated for 3 days, and the triglyceride content was determined as described above.</p></sec><sec id="s4-11"><title>RNA isolation and qPCR gene expression assays</title><p>Total RNA was extracted from cells using RNeasy plus Kit (74034, QIAGEN) together with Qiazol reagent (79306, QIAGEN). RNA purity was assessed using Nanodrop (Nanodrop, Wilmington, USA), and cDNA was synthesized using SuperScript IV VILO Master Mix (11756500, Thermo Fisher Scientific). Then, RT-qPCR was performed on ViiA7 qRT-PCR system (PE Applied Biosystems, Foster City, CA, USA), using predesigned Taqman assays following the manufacturer’s instructions. The Taqman assays (Thermo Fisher Scientific, Uppsala, Sweden) were: <italic>MTIF3</italic> (Hs00794538_m1), <italic>GTF3A</italic> (Hs00157851_m1), <italic>ADIPOQ</italic> (Hs00977214_m1), <italic>PPARG</italic> (Hs01115513_m1), <italic>CEBPA</italic> (Hs00269972_s1), <italic>SREBF1</italic> (Hs02561944_s1), <italic>FASN</italic> (Hs01005622_m1), <italic>TFAM</italic> (Hs01073348_g1), <italic>MT-CO1</italic> (Hs02596864_g1), <italic>PRDM16</italic> (Hs00223161_m1), <italic>TOMM20</italic> (Hs03276810_g1), <italic>CPT1B</italic> (Hs00189258_m1), <italic>ACADM</italic> (<italic>Hs00936584_m1</italic>), <italic>ACAT1</italic> (Hs00608002_m1), <italic>ABHD5</italic> (Hs01104373_m1), <italic>PNP1A2</italic> (Hs00386101_m1), <italic>ACACB</italic> (Hs01565914_m1), <italic>MT-ND1</italic> (Hs02596873_s1), <italic>MT-ND2</italic> (Hs02596874_g1), <italic>MT-ND3</italic> (Hs02596875_s1), <italic>MT-ND4</italic> (Hs02596876_g1), <italic>MT-CO2</italic> (Hs02596865_g1), <italic>MT-CO3</italic> (Hs02596866_g1), <italic>HPRT-1</italic> (Hs99999909_m1), <italic>TBP</italic> (Hs00427620_m1), and <italic>RPL13A</italic> (Hs03043885_g1). The relative gene expression was calculated using the delta Ct method, and the target gene expression was normalized to the mean Ct of three reference genes <italic>HPRT-1</italic>, <italic>TBP</italic>, and <italic>RPL13A</italic>.</p></sec><sec id="s4-12"><title>Western blotting</title><p>Cells were washed twice with ice-cold PBS and lysed in 1% sodium dodecyl sulfate buffer for 10 min, then passed through a QIAshredder (79654, QIAGEN) and centrifuged for 15 min at 14,000 × <italic>g</italic>. The supernatant was subsequently collected and protein concentration quantified using the BCA assays (23225, Thermo Fisher Scientific). To assess target protein expression, 10 μg lysates were loaded into 4–20% Mini-PROTEAN TGX Stain-Free Protein Gels (Bio-Rad Laboratories AB, Solna, Sweden) and separated, followed by transfer of polyvinylidene difluoride (PVDF) membranes (1704156, Bio-Rad Laboratories AB). After blocking in 5% bovine serum albumin (BSA) solution for 1 hr, the membranes were incubated with primary antibodies against MTIF3 (14219-1-AP, Proteintech), OXPHOS complex (45-8199, Thermo Fisher Scientific), FABP4, ACC, FAS (12589, Cell Signalling Technology), ATP8 (26723-1-AP, Proteintech), ND2 (19704-1-AP, Proteintech), CYTB (55090-1-AP, Proteintech), and corresponding horseradish peroxidase (HRP)-conjugated secondary antibodies (anti-mouse IgG, Cell Signalling Technology; anti-rabbit IgG, Cell Signaling Technology). TBS with 0.1% (vol/vol) Tween-20 was used for membrane washing, and TBS with 2% BSA was used for antibody incubation. To visualize the blots, Clarity western ECL substrate was added to the membrane and a CCD camera used to acquire images and Image Lab software (Bio-Rad Laboratories AB, Solna, Sweden) were used to develop the images. ImageJ software was used to quantify the protein bands. After detection of the protein targets, the membranes were stripped using Restore Western Blot Stripping Buffer (21059, Thermo Fisher Scientific) and blotted using anti-β-Actin antibody (4967, Cell Signaling Technology) or anti-GAPDH antibody (ab37168, Abcam).</p></sec><sec id="s4-13"><title>Blue Native polyacrylamide gel electrophoresis and immunoblotting</title><p>Differentiated scrambled control and <italic>MTIF3</italic> knockout hWAs-iCas9 cells were adapted to 5.5 mM glucose growth medium for 3 days to mimic the physiological glucose concentration. The Blue Native polyacrylamide gel electrophoresis (BN-PAGE) was performed as described previously (<xref ref-type="bibr" rid="bib38">Singh and Duchen, 2022</xref>). Briefly, mitochondria were isolated using Mitochondria Isolation Kit (89874, Thermo Fisher Scientific). NativePAGE Sample Prep Kit (BN2008, Invitrogen) was then used for mitochondrial protein extraction and BN-PAGE sample preparation. For native gel electrophoresis, 20 µg mitochondrial protein was loaded to precast 3–12% gradient Blue Native gels (BN1001, Invitrogen) and separated according to the manufacturer’s instructions. The proteins were then electroblotted onto PVDF membrane and probed with anti-OXPHOS antibody cocktail (45-8199, Thermo Fisher Scientific) and a corresponding secondary antibody. The blots were then imaged and analyzed as described above.</p></sec><sec id="s4-14"><title>Relative mitochondrial content measurement</title><p>To examine the effects of <italic>MTIF3</italic> knockout on mitochondrial biogenesis in white adipocytes, relative amount of mtDNA was quantified using a qPCR-based method described previously (<xref ref-type="bibr" rid="bib2">Ajaz et al., 2015</xref>). Briefly, total DNA was extracted and quantified using QIAamp DNA Mini Kit (catalogue number: 56304, QIAGEN) from scrambled control and <italic>MTIF3</italic> knockout cells. For qPCR, equal amounts of total DNA from each sample were mixed with SYBR Green master mix (catalogue number: A25742, Thermo Fisher Scientific) and with primers targeting mitochondrial and nuclear genes, then the samples were run on ViiA7 qRT-PCR system (PE Applied Biosystems, Foster City, CA, USA). The relative mtDNA content was calculated as ΔCt (Ct of nuclear target − Ct of mitochondrial target).</p></sec><sec id="s4-15"><title>Mitochondrial function in <italic>MTIF3</italic> knockout adipocytes</title><p>To directly assess the effects of <italic>MTIF3</italic> on mitochondrial respiration in adipocytes we used the Seahorse XF (Seahorse Bioscience, North Billerica, MA) to measure cellular respiration OCR under different conditions. hWAs-iCas9 cells were seeded at 8000 cells/well in a Seahorse 24-well plate, then differentiated and induced for <italic>MTIF3</italic> knockout or with scrambled control, as described above. Then, cells were adapted in 1 g/l growth medium (31885049, Thermo Fisher Scientific) for 3 days. Mitochondrial function was then assessed using the Seahorse XF-24 instrument according to a protocol optimized for the adipocyte cell line. Briefly, to measure OCR independent of oxidative phosphorylation, 2 μM oligomycin (O4876, Sigma-Aldrich) was added to the cells. Subsequently, 2 μM FCCP (carbonyl cyanide-<italic>p</italic>-trifluoromethoxyphenylhydrazone) (C2920, Sigma-Aldrich) and 5 μM respiratory chain inhibitors: rotenone (R8875, Sigma-Aldrich) and antimycin A (A8674, Sigma-Aldrich) were added to measure maximal respiration and basal rates of non-mitochondrial respiration. Cells were then frozen at −80°C for at least 4 hr, then the plate was dried, and DNA was extracted with CyQUANT Cell Lysis Buffer (C7027, Thermo Fisher Scientific). Total DNA was then quantified by Quant-iT PicoGreen dsDNA Assay Kit (P7589, Thermo Fisher Scientific) against a lambda DNA-generated standard curve.</p></sec><sec id="s4-16"><title>Endogenous long chain fatty acid oxidation in adipocytes</title><p>The Seahorse mitochondrial analyzer was used to test the effects of MTIF3 loss on endogenous long chain fatty acid oxidation in adipocytes. Prior to the assay, adipocytes were incubated overnight with substrate-limited medium: DMEM (A14430, Thermo Fisher Scientific); 0.5 mM glucose (103577-100, Angilent); 1.0 mM glutamine (103579-100, Angilent); 0.5 mM carnitine (C0283, Sigma-Aldrich); 1% FBS (SV30160.03, HyClone). On day of the assay, the substrate-limited medium was replaced with FAO assay medium: 1× Krebs-Henseleit Buffer (KHB) was supplemented with 2.5 mM glucose, 0.5 mM carnitine, and 5 mM N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid (HEPES), and the pH was adjusted to pH 7.4 with NaOH. The cells were then treated for 15 min with either 40 μM etomoxir (E1905, Sigma-Aldrich) or only with the solvent (dimethyl sulfoxide, DMSO). Etomoxir inhibits carnitine palmitoyltransferase (CPT)-1 and diglyceride acyltransferase (DGAT) activity in mitochondria, and thus inhibits mitochondrial fatty acid oxidation (<xref ref-type="bibr" rid="bib44">Xu et al., 2003</xref>; <xref ref-type="bibr" rid="bib14">Griesel et al., 2010</xref>). The OCR was then measured as described above.</p></sec><sec id="s4-17"><title>Mass spectrometry-based metabolite profiling</title><p>The mature hWAs-iCas9 adipocytes were firstly induced for <italic>MTIF3</italic> knockout, followed by glucose restriction challenge as described above. The cells were quenched on dry ice and metabolites were extracted using a previously optimized protocol (<xref ref-type="bibr" rid="bib11">Danielsson et al., 2010</xref>).</p><p>For analysis of low molecular weight metabolites, extracts were reconstituted in 100 µl of MeOH/water (8/2, vol/vol) and 60 µl was transferred to new Eppendorf tubes and evaporated to dryness using a miVac concentrator (SP Scientific, NY) for 3 hr at 30°C. Dried samples were methoximated using 20 µl of methoxyamine hydrochloride in pyridine (Thermo Scientific, MA) by shaking at 3000 rpm for 30 min at room temperature (VWR, PA). Afterward, 20 µl of <italic>N</italic>-methyl-<italic>N</italic>-(trimethylsilyl) trifluoroacetamide (MSTFA) + 1% trimethylsilyl chloride (Thermo Scientific, MA) was added to each sample and shaken at 3000 rpm at room temperature for 1 hr. Samples were transferred to glass vials and immediately analyzed using an Agilent 6890 gas chromatograph connected to an Agilent 5975CL VL MSD mass spectrometer controlled by MassHunter Workstation software 10.0 (Agilent, Atlanta, GA). One µl sample was injected at 270°C on an HP-5MS column (30 m length, 250 µm ID, 0.25 µm phase thickness). with a helium gas flow rate of 1 ml/min and a temperature gradient starting at 70°C for 2 min, increasing 15°C/min to 320°C and held for 2 min. Data were acquired using electron ionization at 70 eV in either full scan (50–550 <italic>m/z</italic>) or single ion monitoring mode. The MS-DIAL version 4.7 was used for raw peak extraction, peak alignment, deconvolution, peak annotation, and integration of peaks.</p><p>Amino acids and free fatty acids were chemically derivatized and analyzed using a previously described method (<xref ref-type="bibr" rid="bib27">Meng et al., 2021</xref>). Briefly, 40 µl of the samples were mixed with 20 µl of 3-nitrophenylhydrazine (3-NPH) (Sigma-Aldrich, MO), followed by addition of 20 µl of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) (Thermo Scientific, MA) and shaking at 3000 rpm at room temperature for 1 hr. Samples were analyzed using an Agilent 1260 ultra-performance liquid chromatograph coupled with an Agilent 6495 tandem mass spectrometer and controlled by MassHunter version 8.0 (Agilent Technologies, CA). Three µl sample was injected on an Agilent Eclipse RRHD C18 column (2.1 × 150 mm, 1.8 µm) (Agilent Technologies, CA) with a flow rate of 0.6 ml/min and a column oven temperature of 50°C. The mobile phases A and B were 0.1% formic acid (Fisher Chemical, Prague, Czech Republic) in Milli-Q water (Merck, Millipore, MO) and acetonitrile (VWR, Paris, France), respectively. Gradient elution was performed as follows: held at 5% B from 0 to 1 min, changed linearly to 90% B in 10 min, changed from 90% B to 100% B in 13 min, held at 100% B for 2 min, returned to 5% B (initial condition) in 0.1 min, and held at 5% B for 2 min. Analyses were conducted in negative electrospray ionization mode (ESI) mode with the nebulizer gas pressure set at 20 psi, ion capillary voltage at 2500 V, gas temperature at 150°C, and sheath gas temperature at 250°C. Data were recorded in multiple reaction monitoring (MRM) mode, with two transitions for each analyte.</p></sec><sec id="s4-18"><title>Lipolysis quantification in differentiated hWAs cells</title><p>Differentiated scrambled control or <italic>MTIF3</italic> knockout cells were washed twice with PBS and then incubated with DMEM containing 2% free fatty acid-free BSA for 2 hr. For the insulin or isoproterenol-stimulated lipolysis, 100 nM insulin (I2643, Sigma-Aldrich) or 10 μM isoproterenol (1351005, Sigma-Aldrich) was added in the medium separately. After the incubation, the medium was collected, and the glycerol content was measured using Glycerol-Glo Assay (J3150, Promega).</p></sec><sec id="s4-19"><title>Total triglyceride measurement</title><p>Triglyceride-Glo Assay kit (J3161, Promega) was used to quantify total triglyceride content in scrambled control or <italic>MTIF3</italic> knockout cells cultured either in 25 mM glucose or glucose restriction medium. Briefly, cells were collected in 50 μl kit lysis buffer at room temperature for 1 hr. Then 2 μl lysate was mixed with 8 μl glycerol lysis solution with lipase, and incubated at 37°C for 30 min. Subsequently, 10 μl glycerol solution was mixed with 10 μl glycerol detection solution supplemented with reductase substrate and kinetic enhancer, and transferred into a 384-well plate. After 1-hr incubation at room temperature, the luminescence was detected using CLARIOstar plate reader (BMG Labtech, Germany), and the triglyceride concentration was calculated using a standard curve generated from glycerol standards and normalized to total protein measured using BCA assays (23227, Thermo Fisher Scientific).</p></sec><sec id="s4-20"><title>Statistics</title><p>For each assay, the number of biological and technical replicates, standard deviation and statistical significance are reported in the figure legends. Hypothesis tests were performed using two-tailed Student’s <italic>t</italic>-test, one-way ANOVA, or paired <italic>t</italic>-test. A nominal p value of &lt;0.05 was considered statistically significant. All analyses were undertaken using Prism GraphPad 9.0 software (La Jolla California, USA), SIMCA 17.0 (Sartorius Stedim Data Analytics, Malmö, Sweden), Rstudio 1.4, and Microsoft Excel 365. For the metabolome data, ANOVA (aov) was performed in R with genotype and glucose concentration as independent variables with Tukey’s test post hoc (TukeyHSD). Significance was defined as <italic>q</italic> &lt; 0.05 using multiple testing adjustment according to the false discovery rate (p.adjust).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Supervision</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Funding acquisition</p></fn><fn fn-type="con" id="con7"><p>Resources, Funding acquisition</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Funding acquisition, Writing – original draft, Project administration</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing – original draft, Project administration</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Design of fine mapping luciferase reporter assays, and association of <italic>MTIF3</italic> locus with adiposity traits in UK Biobank.</title><p>(<bold>a</bold>) Thirty-one SNPs in tight linkage disequilibrium (<italic>r</italic><sup>2</sup> ≥ 0.8) with the lead variant rs1885988 tiled down into 12 DNA segments of the <italic>MTIF3</italic> gene for luciferase reporter assay. To fine map the transcriptional regulatory regions in the <italic>MTIF3</italic> locus, we first identified the common genetic variants which were in tight linkage disequilibrium (<italic>r</italic><sup>2</sup> ≥ 0.8) with the lead variant rs1885988 in <ext-link ext-link-type="uri" xlink:href="https://pubs.broadinstitute.org/mammals/haploreg/haploreg.php">HaploReg v4.1</ext-link>. The identified 31 SNPs were tiled down into 12 DNA segments of the <italic>MTIF3</italic> gene depending on PCR primer design constraints. (<bold>b</bold>) SNPs in <italic>MTIF3</italic> locus associated with body mass index (BMI), whole-body fat mass and arm fat mass (right). We checked the rapid GWAS analysis results from <ext-link ext-link-type="uri" xlink:href="http://www.nealelab.is/blog/2017/7/19/rapid-gwas-of-thousands-of-phenotypes-for-337000-samples-in-the-uk-biobank">337,000 samples in the UK Biobank</ext-link>, which were made available by Benjamin Neale’s lab and visualized in <ext-link ext-link-type="uri" xlink:href="http://big.stats.ox.ac.uk/">Oxford BIG browser</ext-link>, we found SNPs in <italic>MTIF3</italic> locus showed nominal associations with body weight-related traits including BMI, whole-body fat mass and arm fat mass (right).</p></caption><media xlink:href="elife-84168-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-84168-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed in this study are included in the figures and the source data files. Source data files are provided for Figures 3 and 4, and for Figure 3—figure supplement 1.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Jennifer Doudna (UC Berkeley) for initial support with concepts relating to using CRISPR in in vitro studies of gene–environment interactions. We also thank Yu-Hua Tseng in Joslin Diabetes Centre for providing the hWAs cells.</p><p>This work was supported by China Scholarship Council (201708420158 to Mi Huang); the European Commission (ERC-2015-CoG-681742 NASCENT to PWF), and Swedish Research Council (Distinguish Young Research Reward in Medicine) (to PWF), LUDC-IRC and The Swedish Research Council (to HM), and by The Albert Påhlsson Foundation (to SK).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>KF</given-names></name><name><surname>Schatzkin</surname><given-names>A</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Kipnis</surname><given-names>V</given-names></name><name><surname>Mouw</surname><given-names>T</given-names></name><name><surname>Ballard-Barbash</surname><given-names>R</given-names></name><name><surname>Hollenbeck</surname><given-names>A</given-names></name><name><surname>Leitzmann</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old</article-title><source>The New England Journal of Medicine</source><volume>355</volume><fpage>763</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa055643</pub-id><pub-id pub-id-type="pmid">16926275</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajaz</surname><given-names>S</given-names></name><name><surname>Czajka</surname><given-names>A</given-names></name><name><surname>Malik</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Accurate measurement of circulating mitochondrial DNA content from human blood samples using real-time quantitative PCR</article-title><source>Methods in Molecular Biology</source><volume>1264</volume><fpage>117</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-2257-4_12</pub-id><pub-id pub-id-type="pmid">25789388</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appleton</surname><given-names>SL</given-names></name><name><surname>Seaborn</surname><given-names>CJ</given-names></name><name><surname>Visvanathan</surname><given-names>R</given-names></name><name><surname>Hill</surname><given-names>CL</given-names></name><name><surname>Gill</surname><given-names>TK</given-names></name><name><surname>Taylor</surname><given-names>AW</given-names></name><name><surname>Adams</surname><given-names>RJ</given-names></name><name><surname>North West Adelaide Health Study</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study</article-title><source>Diabetes Care</source><volume>36</volume><fpage>2388</fpage><lpage>2394</lpage><pub-id pub-id-type="doi">10.2337/dc12-1971</pub-id><pub-id pub-id-type="pmid">23491523</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aprile</surname><given-names>M</given-names></name><name><surname>Cataldi</surname><given-names>S</given-names></name><name><surname>Perfetto</surname><given-names>C</given-names></name><name><surname>Ambrosio</surname><given-names>MR</given-names></name><name><surname>Italiani</surname><given-names>P</given-names></name><name><surname>Tatè</surname><given-names>R</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Ciccodicola</surname><given-names>A</given-names></name><name><surname>Costa</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>In-vitro-generated hypertrophic-like adipocytes displaying PPARG isoforms unbalance recapitulate adipocyte dysfunctions in vivo</article-title><source>Cells</source><volume>9</volume><elocation-id>1284</elocation-id><pub-id pub-id-type="doi">10.3390/cells9051284</pub-id><pub-id pub-id-type="pmid">32455814</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhargava</surname><given-names>K</given-names></name><name><surname>Spremulli</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Role of the N- and C-terminal extensions on the activity of mammalian mitochondrial translational initiation factor 3</article-title><source>Nucleic Acids Research</source><volume>33</volume><fpage>7011</fpage><lpage>7018</lpage><pub-id pub-id-type="doi">10.1093/nar/gki1007</pub-id><pub-id pub-id-type="pmid">16340009</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Böhm</surname><given-names>A</given-names></name><name><surname>Keuper</surname><given-names>M</given-names></name><name><surname>Meile</surname><given-names>T</given-names></name><name><surname>Zdichavsky</surname><given-names>M</given-names></name><name><surname>Fritsche</surname><given-names>A</given-names></name><name><surname>Häring</surname><given-names>HU</given-names></name><name><surname>de Angelis</surname><given-names>MH</given-names></name><name><surname>Staiger</surname><given-names>H</given-names></name><name><surname>Franko</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Increased mitochondrial respiration of adipocytes from metabolically unhealthy obese compared to healthy obese individuals</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>12407</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-69016-9</pub-id><pub-id pub-id-type="pmid">32709986</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boudina</surname><given-names>S</given-names></name><name><surname>Graham</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondrial function/dysfunction in white adipose tissue</article-title><source>Experimental Physiology</source><volume>99</volume><fpage>1168</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1113/expphysiol.2014.081414</pub-id><pub-id pub-id-type="pmid">25128326</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chicherin</surname><given-names>IV</given-names></name><name><surname>Baleva</surname><given-names>MV</given-names></name><name><surname>Levitskii</surname><given-names>SA</given-names></name><name><surname>Dashinimaev</surname><given-names>EB</given-names></name><name><surname>Krasheninnikov</surname><given-names>IA</given-names></name><name><surname>Kamenski</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Initiation factor 3 is dispensable for mitochondrial translation in cultured human cells</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>7110</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-64139-5</pub-id><pub-id pub-id-type="pmid">32346061</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>AY</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Fisher</surname><given-names>VA</given-names></name><name><surname>Drong</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Liu</surname><given-names>C-T</given-names></name><name><surname>Weeks</surname><given-names>O</given-names></name><name><surname>Choh</surname><given-names>AC</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Dyer</surname><given-names>TD</given-names></name><name><surname>Eicher</surname><given-names>JD</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Heard-Costa</surname><given-names>NL</given-names></name><name><surname>Kacprowski</surname><given-names>T</given-names></name><name><surname>Kent</surname><given-names>JW</given-names><suffix>Jr</suffix></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Lohman</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>O’Connell</surname><given-names>JR</given-names></name><name><surname>Parihar</surname><given-names>A</given-names></name><name><surname>Peralta</surname><given-names>JM</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Homuth</surname><given-names>G</given-names></name><name><surname>Kissebah</surname><given-names>AH</given-names></name><name><surname>Kullberg</surname><given-names>J</given-names></name><name><surname>Laqua</surname><given-names>R</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Nauck</surname><given-names>M</given-names></name><name><surname>Olivier</surname><given-names>M</given-names></name><name><surname>Peyser</surname><given-names>PA</given-names></name><name><surname>Terry</surname><given-names>JG</given-names></name><name><surname>Wojczynski</surname><given-names>MK</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Bielak</surname><given-names>LF</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Borecki</surname><given-names>IB</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Carr</surname><given-names>JJ</given-names></name><name><surname>Czerwinski</surname><given-names>SA</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Friedrich</surname><given-names>N</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Kardia</surname><given-names>SLR</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Mosley</surname><given-names>TH</given-names><suffix>Jr</suffix></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Towne</surname><given-names>B</given-names></name><name><surname>Völzke</surname><given-names>H</given-names></name><name><surname>Wallaschofski</surname><given-names>H</given-names></name><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Allison</surname><given-names>M</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Goessling</surname><given-names>W</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Steinhauser</surname><given-names>ML</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation</article-title><source>Nature Genetics</source><volume>49</volume><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1038/ng.3738</pub-id><pub-id pub-id-type="pmid">27918534</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Civitarese</surname><given-names>AE</given-names></name><name><surname>Carling</surname><given-names>S</given-names></name><name><surname>Heilbronn</surname><given-names>LK</given-names></name><name><surname>Hulver</surname><given-names>MH</given-names></name><name><surname>Ukropcova</surname><given-names>B</given-names></name><name><surname>Deutsch</surname><given-names>WA</given-names></name><name><surname>Smith</surname><given-names>SR</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name><collab>CALERIE Pennington Team</collab></person-group><year iso-8601-date="2007">2007</year><article-title>Calorie restriction increases muscle mitochondrial biogenesis in healthy humans</article-title><source>PLOS Medicine</source><volume>4</volume><elocation-id>e76</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0040076</pub-id><pub-id pub-id-type="pmid">17341128</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danielsson</surname><given-names>APH</given-names></name><name><surname>Moritz</surname><given-names>T</given-names></name><name><surname>Mulder</surname><given-names>H</given-names></name><name><surname>Spégel</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Development and optimization of a metabolomic method for analysis of adherent cell cultures</article-title><source>Analytical Biochemistry</source><volume>404</volume><fpage>30</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2010.04.013</pub-id><pub-id pub-id-type="pmid">20417172</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>GV</given-names></name><name><surname>Obin</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>“ metabolically healthy obesity ”: origins and implications</article-title><source>Molecular Aspects of Medicine</source><volume>34</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2012.10.004</pub-id><pub-id pub-id-type="pmid">23068072</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregoire</surname><given-names>FM</given-names></name><name><surname>Smas</surname><given-names>CM</given-names></name><name><surname>Sul</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Understanding adipocyte differentiation</article-title><source>Physiological Reviews</source><volume>78</volume><fpage>783</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1152/physrev.1998.78.3.783</pub-id><pub-id pub-id-type="pmid">9674695</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griesel</surname><given-names>BA</given-names></name><name><surname>Weems</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>RA</given-names></name><name><surname>Abel</surname><given-names>ED</given-names></name><name><surname>Humphries</surname><given-names>K</given-names></name><name><surname>Olson</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Acute inhibition of fatty acid import inhibits GLUT4 transcription in adipose tissue, but not skeletal or cardiac muscle tissue, partly through liver X receptor (LXR) signaling</article-title><source>Diabetes</source><volume>59</volume><fpage>800</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.2337/db09-1542</pub-id><pub-id pub-id-type="pmid">20103707</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>A</given-names></name><name><surname>Hance</surname><given-names>N</given-names></name><name><surname>Dufour</surname><given-names>E</given-names></name><name><surname>Rantanen</surname><given-names>A</given-names></name><name><surname>Hultenby</surname><given-names>K</given-names></name><name><surname>Clayton</surname><given-names>DA</given-names></name><name><surname>Wibom</surname><given-names>R</given-names></name><name><surname>Larsson</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts</article-title><source>PNAS</source><volume>101</volume><fpage>3136</fpage><lpage>3141</lpage><pub-id pub-id-type="doi">10.1073/pnas.0308710100</pub-id><pub-id pub-id-type="pmid">14978272</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinonen</surname><given-names>S</given-names></name><name><surname>Buzkova</surname><given-names>J</given-names></name><name><surname>Muniandy</surname><given-names>M</given-names></name><name><surname>Kaksonen</surname><given-names>R</given-names></name><name><surname>Ollikainen</surname><given-names>M</given-names></name><name><surname>Ismail</surname><given-names>K</given-names></name><name><surname>Hakkarainen</surname><given-names>A</given-names></name><name><surname>Lundbom</surname><given-names>J</given-names></name><name><surname>Lundbom</surname><given-names>N</given-names></name><name><surname>Vuolteenaho</surname><given-names>K</given-names></name><name><surname>Moilanen</surname><given-names>E</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Rissanen</surname><given-names>A</given-names></name><name><surname>Suomalainen</surname><given-names>A</given-names></name><name><surname>Pietiläinen</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Impaired mitochondrial biogenesis in adipose tissue in acquired obesity</article-title><source>Diabetes</source><volume>64</volume><fpage>3135</fpage><lpage>3145</lpage><pub-id pub-id-type="doi">10.2337/db14-1937</pub-id><pub-id pub-id-type="pmid">25972572</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinonen</surname><given-names>S</given-names></name><name><surname>Jokinen</surname><given-names>R</given-names></name><name><surname>Rissanen</surname><given-names>A</given-names></name><name><surname>Pietiläinen</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>White adipose tissue mitochondrial metabolism in health and in obesity</article-title><source>Obesity Reviews</source><volume>21</volume><elocation-id>e12958</elocation-id><pub-id pub-id-type="doi">10.1111/obr.12958</pub-id><pub-id pub-id-type="pmid">31777187</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jokinen</surname><given-names>R</given-names></name><name><surname>Rinnankoski-Tuikka</surname><given-names>R</given-names></name><name><surname>Kaye</surname><given-names>S</given-names></name><name><surname>Saarinen</surname><given-names>L</given-names></name><name><surname>Heinonen</surname><given-names>S</given-names></name><name><surname>Myöhänen</surname><given-names>M</given-names></name><name><surname>Rappou</surname><given-names>E</given-names></name><name><surname>Jukarainen</surname><given-names>S</given-names></name><name><surname>Rissanen</surname><given-names>A</given-names></name><name><surname>Pessia</surname><given-names>A</given-names></name><name><surname>Velagapudi</surname><given-names>V</given-names></name><name><surname>Virtanen</surname><given-names>KA</given-names></name><name><surname>Pirinen</surname><given-names>E</given-names></name><name><surname>Pietiläinen</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Adipose tissue mitochondrial capacity associates with long-term weight loss success</article-title><source>International Journal of Obesity</source><volume>42</volume><fpage>817</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1038/ijo.2017.299</pub-id><pub-id pub-id-type="pmid">29203860</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaaman</surname><given-names>M</given-names></name><name><surname>Sparks</surname><given-names>LM</given-names></name><name><surname>van Harmelen</surname><given-names>V</given-names></name><name><surname>Smith</surname><given-names>SR</given-names></name><name><surname>Sjölin</surname><given-names>E</given-names></name><name><surname>Dahlman</surname><given-names>I</given-names></name><name><surname>Arner</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue</article-title><source>Diabetologia</source><volume>50</volume><fpage>2526</fpage><lpage>2533</lpage><pub-id pub-id-type="doi">10.1007/s00125-007-0818-6</pub-id><pub-id pub-id-type="pmid">17879081</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamble</surname><given-names>PG</given-names></name><name><surname>Hetty</surname><given-names>S</given-names></name><name><surname>Vranic</surname><given-names>M</given-names></name><name><surname>Almby</surname><given-names>K</given-names></name><name><surname>Castillejo-López</surname><given-names>C</given-names></name><name><surname>Abalo</surname><given-names>XM</given-names></name><name><surname>Pereira</surname><given-names>MJ</given-names></name><name><surname>Eriksson</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Proof-of-concept for CRISPR/cas9 gene editing in human preadipocytes: deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>10565</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-67293-y</pub-id><pub-id pub-id-type="pmid">32601291</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuzmenko</surname><given-names>A</given-names></name><name><surname>Atkinson</surname><given-names>GC</given-names></name><name><surname>Levitskii</surname><given-names>S</given-names></name><name><surname>Zenkin</surname><given-names>N</given-names></name><name><surname>Tenson</surname><given-names>T</given-names></name><name><surname>Hauryliuk</surname><given-names>V</given-names></name><name><surname>Kamenski</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mitochondrial translation initiation machinery: conservation and diversification</article-title><source>Biochimie</source><volume>100</volume><fpage>132</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2013.07.024</pub-id><pub-id pub-id-type="pmid">23954798</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson-Meyer</surname><given-names>DE</given-names></name><name><surname>Heilbronn</surname><given-names>LK</given-names></name><name><surname>Redman</surname><given-names>LM</given-names></name><name><surname>Newcomer</surname><given-names>BR</given-names></name><name><surname>Frisard</surname><given-names>MI</given-names></name><name><surname>Anton</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>SR</given-names></name><name><surname>Alfonso</surname><given-names>A</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects</article-title><source>Diabetes Care</source><volume>29</volume><fpage>1337</fpage><lpage>1344</lpage><pub-id pub-id-type="doi">10.2337/dc05-2565</pub-id><pub-id pub-id-type="pmid">16732018</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locke</surname><given-names>AE</given-names></name><name><surname>Kahali</surname><given-names>B</given-names></name><name><surname>Berndt</surname><given-names>SI</given-names></name><name><surname>Justice</surname><given-names>AE</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Day</surname><given-names>FR</given-names></name><name><surname>Powell</surname><given-names>C</given-names></name><name><surname>Vedantam</surname><given-names>S</given-names></name><name><surname>Buchkovich</surname><given-names>ML</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Croteau-Chonka</surname><given-names>DC</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Fall</surname><given-names>T</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name><name><surname>Gustafsson</surname><given-names>S</given-names></name><name><surname>Kutalik</surname><given-names>Z</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Randall</surname><given-names>JC</given-names></name><name><surname>Winkler</surname><given-names>TW</given-names></name><name><surname>Wood</surname><given-names>AR</given-names></name><name><surname>Workalemahu</surname><given-names>T</given-names></name><name><surname>Faul</surname><given-names>JD</given-names></name><name><surname>Smith</surname><given-names>JA</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Fehrmann</surname><given-names>R</given-names></name><name><surname>Hedman</surname><given-names>ÅK</given-names></name><name><surname>Karjalainen</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>EM</given-names></name><name><surname>Absher</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>D</given-names></name><name><surname>Beekman</surname><given-names>M</given-names></name><name><surname>Bolton</surname><given-names>JL</given-names></name><name><surname>Bragg-Gresham</surname><given-names>JL</given-names></name><name><surname>Buyske</surname><given-names>S</given-names></name><name><surname>Demirkan</surname><given-names>A</given-names></name><name><surname>Deng</surname><given-names>G</given-names></name><name><surname>Ehret</surname><given-names>GB</given-names></name><name><surname>Feenstra</surname><given-names>B</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Kleber</surname><given-names>ME</given-names></name><name><surname>Kristiansson</surname><given-names>K</given-names></name><name><surname>Lim</surname><given-names>U</given-names></name><name><surname>Lotay</surname><given-names>V</given-names></name><name><surname>Mangino</surname><given-names>M</given-names></name><name><surname>Leach</surname><given-names>IM</given-names></name><name><surname>Medina-Gomez</surname><given-names>C</given-names></name><name><surname>Medland</surname><given-names>SE</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Palmer</surname><given-names>CD</given-names></name><name><surname>Pasko</surname><given-names>D</given-names></name><name><surname>Pechlivanis</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>MJ</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Shungin</surname><given-names>D</given-names></name><name><surname>Stančáková</surname><given-names>A</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Sung</surname><given-names>YJ</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Trompet</surname><given-names>S</given-names></name><name><surname>van der Laan</surname><given-names>SW</given-names></name><name><surname>van Setten</surname><given-names>J</given-names></name><name><surname>Van Vliet-Ostaptchouk</surname><given-names>JV</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Albrecht</surname><given-names>E</given-names></name><name><surname>Ärnlöv</surname><given-names>J</given-names></name><name><surname>Arscott</surname><given-names>GM</given-names></name><name><surname>Attwood</surname><given-names>AP</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Barrett</surname><given-names>A</given-names></name><name><surname>Bas</surname><given-names>IN</given-names></name><name><surname>Bellis</surname><given-names>C</given-names></name><name><surname>Bennett</surname><given-names>AJ</given-names></name><name><surname>Berne</surname><given-names>C</given-names></name><name><surname>Blagieva</surname><given-names>R</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Böhringer</surname><given-names>S</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Böttcher</surname><given-names>Y</given-names></name><name><surname>Boyd</surname><given-names>HA</given-names></name><name><surname>Bruinenberg</surname><given-names>M</given-names></name><name><surname>Caspersen</surname><given-names>IH</given-names></name><name><surname>Chen</surname><given-names>Y-DI</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Daw</surname><given-names>EW</given-names></name><name><surname>de Craen</surname><given-names>AJM</given-names></name><name><surname>Delgado</surname><given-names>G</given-names></name><name><surname>Dimitriou</surname><given-names>M</given-names></name><name><surname>Doney</surname><given-names>ASF</given-names></name><name><surname>Eklund</surname><given-names>N</given-names></name><name><surname>Estrada</surname><given-names>K</given-names></name><name><surname>Eury</surname><given-names>E</given-names></name><name><surname>Folkersen</surname><given-names>L</given-names></name><name><surname>Fraser</surname><given-names>RM</given-names></name><name><surname>Garcia</surname><given-names>ME</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>Gigante</surname><given-names>B</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Golay</surname><given-names>A</given-names></name><name><surname>Goodall</surname><given-names>AH</given-names></name><name><surname>Gordon</surname><given-names>SD</given-names></name><name><surname>Gorski</surname><given-names>M</given-names></name><name><surname>Grabe</surname><given-names>H-J</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Grammer</surname><given-names>TB</given-names></name><name><surname>Gräßler</surname><given-names>J</given-names></name><name><surname>Grönberg</surname><given-names>H</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Gusto</surname><given-names>G</given-names></name><name><surname>Haessler</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>P</given-names></name><name><surname>Haller</surname><given-names>T</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Hartman</surname><given-names>CA</given-names></name><name><surname>Hassinen</surname><given-names>M</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Heard-Costa</surname><given-names>NL</given-names></name><name><surname>Helmer</surname><given-names>Q</given-names></name><name><surname>Hengstenberg</surname><given-names>C</given-names></name><name><surname>Holmen</surname><given-names>O</given-names></name><name><surname>Hottenga</surname><given-names>J-J</given-names></name><name><surname>James</surname><given-names>AL</given-names></name><name><surname>Jeff</surname><given-names>JM</given-names></name><name><surname>Johansson</surname><given-names>Å</given-names></name><name><surname>Jolley</surname><given-names>J</given-names></name><name><surname>Juliusdottir</surname><given-names>T</given-names></name><name><surname>Kinnunen</surname><given-names>L</given-names></name><name><surname>Koenig</surname><given-names>W</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Kratzer</surname><given-names>W</given-names></name><name><surname>Laitinen</surname><given-names>J</given-names></name><name><surname>Lamina</surname><given-names>C</given-names></name><name><surname>Leander</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>NR</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Lindström</surname><given-names>J</given-names></name><name><surname>Lo</surname><given-names>KS</given-names></name><name><surname>Lobbens</surname><given-names>S</given-names></name><name><surname>Lorbeer</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Mach</surname><given-names>F</given-names></name><name><surname>Magnusson</surname><given-names>PKE</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>McArdle</surname><given-names>WL</given-names></name><name><surname>McLachlan</surname><given-names>S</given-names></name><name><surname>Menni</surname><given-names>C</given-names></name><name><surname>Merger</surname><given-names>S</given-names></name><name><surname>Mihailov</surname><given-names>E</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Moayyeri</surname><given-names>A</given-names></name><name><surname>Monda</surname><given-names>KL</given-names></name><name><surname>Morken</surname><given-names>MA</given-names></name><name><surname>Mulas</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>G</given-names></name><name><surname>Müller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Musk</surname><given-names>AW</given-names></name><name><surname>Nagaraja</surname><given-names>R</given-names></name><name><surname>Nöthen</surname><given-names>MM</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><name><surname>Pilz</surname><given-names>S</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Renstrom</surname><given-names>F</given-names></name><name><surname>Rettig</surname><given-names>R</given-names></name><name><surname>Ried</surname><given-names>JS</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Robertson</surname><given-names>NR</given-names></name><name><surname>Rose</surname><given-names>LM</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Scharnagl</surname><given-names>H</given-names></name><name><surname>Scholtens</surname><given-names>S</given-names></name><name><surname>Schumacher</surname><given-names>FR</given-names></name><name><surname>Scott</surname><given-names>WR</given-names></name><name><surname>Seufferlein</surname><given-names>T</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Smolonska</surname><given-names>J</given-names></name><name><surname>Stanton</surname><given-names>AV</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Stirrups</surname><given-names>K</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Sundström</surname><given-names>J</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>Swift</surname><given-names>AJ</given-names></name><name><surname>Syvänen</surname><given-names>A-C</given-names></name><name><surname>Tan</surname><given-names>S-T</given-names></name><name><surname>Tayo</surname><given-names>BO</given-names></name><name><surname>Thorand</surname><given-names>B</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Tyrer</surname><given-names>JP</given-names></name><name><surname>Uh</surname><given-names>H-W</given-names></name><name><surname>Vandenput</surname><given-names>L</given-names></name><name><surname>Verhulst</surname><given-names>FC</given-names></name><name><surname>Vermeulen</surname><given-names>SH</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Vonk</surname><given-names>JM</given-names></name><name><surname>Waite</surname><given-names>LL</given-names></name><name><surname>Warren</surname><given-names>HR</given-names></name><name><surname>Waterworth</surname><given-names>D</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Wilkens</surname><given-names>LR</given-names></name><name><surname>Willenborg</surname><given-names>C</given-names></name><name><surname>Wilsgaard</surname><given-names>T</given-names></name><name><surname>Wojczynski</surname><given-names>MK</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>AF</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Brennan</surname><given-names>EP</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Dastani</surname><given-names>Z</given-names></name><name><surname>Drong</surname><given-names>AW</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Franco-Cereceda</surname><given-names>A</given-names></name><name><surname>Gådin</surname><given-names>JR</given-names></name><name><surname>Gharavi</surname><given-names>AG</given-names></name><name><surname>Goddard</surname><given-names>ME</given-names></name><name><surname>Handsaker</surname><given-names>RE</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Keildson</surname><given-names>S</given-names></name><name><surname>Kiryluk</surname><given-names>K</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>J-Y</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Lifton</surname><given-names>RP</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>McKnight</surname><given-names>AJ</given-names></name><name><surname>Min</surname><given-names>JL</given-names></name><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Murabito</surname><given-names>JM</given-names></name><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>Dorajoo</surname><given-names>R</given-names></name><name><surname>Reinmaa</surname><given-names>E</given-names></name><name><surname>Salem</surname><given-names>RM</given-names></name><name><surname>Sandholm</surname><given-names>N</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Stolk</surname><given-names>L</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>van ’t Hooft</surname><given-names>FM</given-names></name><name><surname>Vinkhuyzen</surname><given-names>AAE</given-names></name><name><surname>Westra</surname><given-names>H-J</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Zondervan</surname><given-names>KT</given-names></name><name><surname>Heath</surname><given-names>AC</given-names></name><name><surname>Arveiler</surname><given-names>D</given-names></name><name><surname>Bakker</surname><given-names>SJL</given-names></name><name><surname>Beilby</surname><given-names>J</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Bovet</surname><given-names>P</given-names></name><name><surname>Campbell</surname><given-names>H</given-names></name><name><surname>Caulfield</surname><given-names>MJ</given-names></name><name><surname>Cesana</surname><given-names>G</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Crawford</surname><given-names>DC</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Cusi</surname><given-names>D</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name><name><surname>den Ruijter</surname><given-names>HM</given-names></name><name><surname>Dominiczak</surname><given-names>AF</given-names></name><name><surname>Erbel</surname><given-names>R</given-names></name><name><surname>Erdmann</surname><given-names>J</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Farrall</surname><given-names>M</given-names></name><name><surname>Felix</surname><given-names>SB</given-names></name><name><surname>Ferrannini</surname><given-names>E</given-names></name><name><surname>Ferrières</surname><given-names>J</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Forouhi</surname><given-names>NG</given-names></name><name><surname>Forrester</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Gansevoort</surname><given-names>RT</given-names></name><name><surname>Gejman</surname><given-names>PV</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Gottesman</surname><given-names>O</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Gyllensten</surname><given-names>U</given-names></name><name><surname>Hall</surname><given-names>AS</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Hicks</surname><given-names>AA</given-names></name><name><surname>Hindorff</surname><given-names>LA</given-names></name><name><surname>Hingorani</surname><given-names>AD</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Homuth</surname><given-names>G</given-names></name><name><surname>Hovingh</surname><given-names>GK</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name><name><surname>Hunt</surname><given-names>SC</given-names></name><name><surname>Hyppönen</surname><given-names>E</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Jacobs</surname><given-names>KB</given-names></name><name><surname>Jarvelin</surname><given-names>M-R</given-names></name><name><surname>Jöckel</surname><given-names>K-H</given-names></name><name><surname>Johansen</surname><given-names>B</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Jukema</surname><given-names>JW</given-names></name><name><surname>Jula</surname><given-names>AM</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Kastelein</surname><given-names>JJP</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname><given-names>SM</given-names></name><name><surname>Kiemeney</surname><given-names>LA</given-names></name><name><surname>Knekt</surname><given-names>P</given-names></name><name><surname>Kooner</surname><given-names>JS</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Kraja</surname><given-names>AT</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Marchand</surname><given-names>LL</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Männistö</surname><given-names>S</given-names></name><name><surname>Marette</surname><given-names>A</given-names></name><name><surname>Matise</surname><given-names>TC</given-names></name><name><surname>McKenzie</surname><given-names>CA</given-names></name><name><surname>McKnight</surname><given-names>B</given-names></name><name><surname>Moll</surname><given-names>FL</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Murray</surname><given-names>JC</given-names></name><name><surname>Nelis</surname><given-names>M</given-names></name><name><surname>Ohlsson</surname><given-names>C</given-names></name><name><surname>Oldehinkel</surname><given-names>AJ</given-names></name><name><surname>Ong</surname><given-names>KK</given-names></name><name><surname>Madden</surname><given-names>PAF</given-names></name><name><surname>Pasterkamp</surname><given-names>G</given-names></name><name><surname>Peden</surname><given-names>JF</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Postma</surname><given-names>DS</given-names></name><name><surname>Pramstaller</surname><given-names>PP</given-names></name><name><surname>Price</surname><given-names>JF</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Rankinen</surname><given-names>T</given-names></name><name><surname>Rao</surname><given-names>DC</given-names></name><name><surname>Rice</surname><given-names>TK</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Rioux</surname><given-names>JD</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Saramies</surname><given-names>J</given-names></name><name><surname>Sarzynski</surname><given-names>MA</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name><name><surname>Schwarz</surname><given-names>PEH</given-names></name><name><surname>Sever</surname><given-names>P</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Sinisalo</surname><given-names>J</given-names></name><name><surname>Stolk</surname><given-names>RP</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Tönjes</surname><given-names>A</given-names></name><name><surname>Trégouët</surname><given-names>D-A</given-names></name><name><surname>Tremblay</surname><given-names>A</given-names></name><name><surname>Tremoli</surname><given-names>E</given-names></name><name><surname>Virtamo</surname><given-names>J</given-names></name><name><surname>Vohl</surname><given-names>M-C</given-names></name><name><surname>Völker</surname><given-names>U</given-names></name><name><surname>Waeber</surname><given-names>G</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Zillikens</surname><given-names>MC</given-names></name><name><surname>Adair</surname><given-names>LS</given-names></name><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Asselbergs</surname><given-names>FW</given-names></name><name><surname>Assimes</surname><given-names>TL</given-names></name><name><surname>Bochud</surname><given-names>M</given-names></name><name><surname>Boehm</surname><given-names>BO</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Bornstein</surname><given-names>SR</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Cooper</surname><given-names>RS</given-names></name><name><surname>de Bakker</surname><given-names>PIW</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Hui</surname><given-names>J</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Kaplan</surname><given-names>RC</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Kuh</surname><given-names>D</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>März</surname><given-names>W</given-names></name><name><surname>Melbye</surname><given-names>M</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Moebus</surname><given-names>S</given-names></name><name><surname>Munroe</surname><given-names>PB</given-names></name><name><surname>Njølstad</surname><given-names>I</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Pérusse</surname><given-names>L</given-names></name><name><surname>Peters</surname><given-names>U</given-names></name><name><surname>Power</surname><given-names>C</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name><name><surname>Rauramaa</surname><given-names>R</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Saaristo</surname><given-names>TE</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name><name><surname>Slagboom</surname><given-names>PE</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Uusitupa</surname><given-names>M</given-names></name><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Wallaschofski</surname><given-names>H</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Watkins</surname><given-names>H</given-names></name><name><surname>Weir</surname><given-names>DR</given-names></name><name><surname>Wichmann</surname><given-names>H-E</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Zanen</surname><given-names>P</given-names></name><name><surname>Borecki</surname><given-names>IB</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>O’Connell</surname><given-names>JR</given-names></name><name><surname>Strachan</surname><given-names>DP</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Scherag</surname><given-names>A</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Beckmann</surname><given-names>JS</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Speliotes</surname><given-names>EK</given-names></name><collab>LifeLines Cohort Study</collab><collab>ADIPOGen Consortium</collab><collab>AGEN-BMI Working Group</collab><collab>CARDIOGRAMplusC4D Consortium</collab><collab>CKDGen Consortium</collab><collab>GLGC</collab><collab>ICBP</collab><collab>MAGIC Investigators</collab><collab>MuTHER Consortium</collab><collab>MIGen Consortium</collab><collab>PAGE Consortium</collab><collab>ReproGen Consortium</collab><collab>GENIE Consortium</collab><collab>International Endogene Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic studies of body mass index yield new insights for obesity biology</article-title><source>Nature</source><volume>518</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1038/nature14177</pub-id><pub-id pub-id-type="pmid">25673413</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lotta</surname><given-names>LA</given-names></name><name><surname>Wittemans</surname><given-names>LBL</given-names></name><name><surname>Zuber</surname><given-names>V</given-names></name><name><surname>Stewart</surname><given-names>ID</given-names></name><name><surname>Sharp</surname><given-names>SJ</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Day</surname><given-names>FR</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Bowker</surname><given-names>N</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>De Lucia Rolfe</surname><given-names>E</given-names></name><name><surname>Khaw</surname><given-names>K-T</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>O’Rahilly</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Savage</surname><given-names>DB</given-names></name><name><surname>Burgess</surname><given-names>S</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Association of genetic variants related to gluteofemoral vs abdominal fat distribution with type 2 diabetes, coronary disease, and cardiovascular risk factors</article-title><source>JAMA</source><volume>320</volume><fpage>2553</fpage><lpage>2563</lpage><pub-id pub-id-type="doi">10.1001/jama.2018.19329</pub-id><pub-id pub-id-type="pmid">30575882</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maechler</surname><given-names>P</given-names></name><name><surname>Wollheim</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Mitochondrial function in normal and diabetic beta-cells</article-title><source>Nature</source><volume>414</volume><fpage>807</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1038/414807a</pub-id><pub-id pub-id-type="pmid">11742413</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>CE</given-names></name><name><surname>Rosander</surname><given-names>J</given-names></name><name><surname>Gottfried</surname><given-names>J</given-names></name><name><surname>Dennis</surname><given-names>E</given-names></name><name><surname>Dus</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dietary sugar inhibits satiation by decreasing the central processing of sweet taste</article-title><source>eLife</source><volume>9</volume><elocation-id>e54530</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.54530</pub-id><pub-id pub-id-type="pmid">32539934</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X</given-names></name><name><surname>Pang</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Yao</surname><given-names>K</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Simultaneous 3-nitrophenylhydrazine derivatization strategy of carbonyl, carboxyl and phosphoryl submetabolome for LC-MS/MS-based targeted metabolomics with improved sensitivity and coverage</article-title><source>Analytical Chemistry</source><volume>93</volume><fpage>10075</fpage><lpage>10083</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.1c00767</pub-id><pub-id pub-id-type="pmid">34270209</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nettleton</surname><given-names>JA</given-names></name><name><surname>Follis</surname><given-names>JL</given-names></name><name><surname>Ngwa</surname><given-names>JS</given-names></name><name><surname>Smith</surname><given-names>CE</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Wojczynski</surname><given-names>MK</given-names></name><name><surname>Voortman</surname><given-names>T</given-names></name><name><surname>Lemaitre</surname><given-names>RN</given-names></name><name><surname>Kristiansson</surname><given-names>K</given-names></name><name><surname>Nuotio</surname><given-names>M-L</given-names></name><name><surname>Houston</surname><given-names>DK</given-names></name><name><surname>Perälä</surname><given-names>M-M</given-names></name><name><surname>Qi</surname><given-names>Q</given-names></name><name><surname>Sonestedt</surname><given-names>E</given-names></name><name><surname>Manichaikul</surname><given-names>A</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Mikkilä</surname><given-names>V</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Harald</surname><given-names>K</given-names></name><name><surname>Mckeown</surname><given-names>NM</given-names></name><name><surname>Johansson</surname><given-names>I</given-names></name><name><surname>Rissanen</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lahti</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Rukh</surname><given-names>G</given-names></name><name><surname>Rich</surname><given-names>S</given-names></name><name><surname>Booij</surname><given-names>L</given-names></name><name><surname>Dmitriou</surname><given-names>M</given-names></name><name><surname>Ax</surname><given-names>E</given-names></name><name><surname>Raitakari</surname><given-names>O</given-names></name><name><surname>Mukamal</surname><given-names>K</given-names></name><name><surname>Männistö</surname><given-names>S</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Jula</surname><given-names>A</given-names></name><name><surname>Ericson</surname><given-names>U</given-names></name><name><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></name><name><surname>Van Rooij</surname><given-names>FJA</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Sjögren</surname><given-names>P</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Djousse</surname><given-names>L</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Stirrups</surname><given-names>K</given-names></name><name><surname>Viikari</surname><given-names>J</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Kalafati</surname><given-names>IP</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Borecki</surname><given-names>IB</given-names></name><name><surname>Knekt</surname><given-names>P</given-names></name><name><surname>Kritchevsky</surname><given-names>SB</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Dedoussis</surname><given-names>GV</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Zillikens</surname><given-names>MC</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Renström</surname><given-names>F</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gene × dietary pattern interactions in obesity: analysis of up to 68 317 adults of European ancestry</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>4728</fpage><lpage>4738</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv186</pub-id><pub-id pub-id-type="pmid">25994509</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papandonatos</surname><given-names>GD</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Pajewski</surname><given-names>NM</given-names></name><name><surname>Delahanty</surname><given-names>LM</given-names></name><name><surname>Peter</surname><given-names>I</given-names></name><name><surname>Erar</surname><given-names>B</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Harden</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Fontanillas</surname><given-names>P</given-names></name><collab>GIANT Consortium</collab><name><surname>Wagenknecht</surname><given-names>LE</given-names></name><name><surname>Kahn</surname><given-names>SE</given-names></name><name><surname>Wing</surname><given-names>RR</given-names></name><name><surname>Jablonski</surname><given-names>KA</given-names></name><name><surname>Huggins</surname><given-names>GS</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>McCaffery</surname><given-names>JM</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><collab>Diabetes Prevention Program and the Look AHEAD Research Groups</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic predisposition to weight loss and regain with lifestyle intervention: analyses from the diabetes prevention program and the look ahead randomized controlled trials</article-title><source>Diabetes</source><volume>64</volume><fpage>4312</fpage><lpage>4321</lpage><pub-id pub-id-type="doi">10.2337/db15-0441</pub-id><pub-id pub-id-type="pmid">26253612</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phielix</surname><given-names>E</given-names></name><name><surname>Meex</surname><given-names>R</given-names></name><name><surname>Moonen-Kornips</surname><given-names>E</given-names></name><name><surname>Hesselink</surname><given-names>MKC</given-names></name><name><surname>Schrauwen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals</article-title><source>Diabetologia</source><volume>53</volume><fpage>1714</fpage><lpage>1721</lpage><pub-id pub-id-type="doi">10.1007/s00125-010-1764-2</pub-id><pub-id pub-id-type="pmid">20422397</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietiläinen</surname><given-names>KH</given-names></name><name><surname>Naukkarinen</surname><given-names>J</given-names></name><name><surname>Rissanen</surname><given-names>A</given-names></name><name><surname>Saharinen</surname><given-names>J</given-names></name><name><surname>Ellonen</surname><given-names>P</given-names></name><name><surname>Keränen</surname><given-names>H</given-names></name><name><surname>Suomalainen</surname><given-names>A</given-names></name><name><surname>Götz</surname><given-names>A</given-names></name><name><surname>Suortti</surname><given-names>T</given-names></name><name><surname>Yki-Järvinen</surname><given-names>H</given-names></name><name><surname>Oresic</surname><given-names>M</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity</article-title><source>PLOS Medicine</source><volume>5</volume><elocation-id>e51</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0050051</pub-id><pub-id pub-id-type="pmid">18336063</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulos</surname><given-names>SP</given-names></name><name><surname>Dodson</surname><given-names>MV</given-names></name><name><surname>Hausman</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cell line models for differentiation: preadipocytes and adipocytes</article-title><source>Experimental Biology and Medicine</source><volume>235</volume><fpage>1185</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1258/ebm.2010.010063</pub-id><pub-id pub-id-type="pmid">20864461</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen-Torvik</surname><given-names>LJ</given-names></name><name><surname>Baldridge</surname><given-names>AS</given-names></name><name><surname>Pacheco</surname><given-names>JA</given-names></name><name><surname>Aufox</surname><given-names>SA</given-names></name><name><surname>Kim</surname><given-names>K-YA</given-names></name><name><surname>Silverstein</surname><given-names>JC</given-names></name><name><surname>Denham</surname><given-names>EW</given-names></name><name><surname>Hungness</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>ME</given-names></name><name><surname>Greenland</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Rs4771122 predicts multiple measures of long-term weight loss after bariatric surgery</article-title><source>Obesity Surgery</source><volume>25</volume><fpage>2225</fpage><lpage>2229</lpage><pub-id pub-id-type="doi">10.1007/s11695-015-1872-7</pub-id><pub-id pub-id-type="pmid">26337695</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudler</surname><given-names>DL</given-names></name><name><surname>Hughes</surname><given-names>LA</given-names></name><name><surname>Perks</surname><given-names>KL</given-names></name><name><surname>Richman</surname><given-names>TR</given-names></name><name><surname>Kuznetsova</surname><given-names>I</given-names></name><name><surname>Ermer</surname><given-names>JA</given-names></name><name><surname>Abudulai</surname><given-names>LN</given-names></name><name><surname>Shearwood</surname><given-names>AMJ</given-names></name><name><surname>Viola</surname><given-names>HM</given-names></name><name><surname>Hool</surname><given-names>LC</given-names></name><name><surname>Siira</surname><given-names>SJ</given-names></name><name><surname>Rackham</surname><given-names>O</given-names></name><name><surname>Filipovska</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fidelity of translation initiation is required for coordinated respiratory complex assembly</article-title><source>Science Advances</source><volume>5</volume><elocation-id>eaay2118</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aay2118</pub-id><pub-id pub-id-type="pmid">31903419</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Ojeda</surname><given-names>FJ</given-names></name><name><surname>Rupérez</surname><given-names>AI</given-names></name><name><surname>Gomez-Llorente</surname><given-names>C</given-names></name><name><surname>Gil</surname><given-names>A</given-names></name><name><surname>Aguilera</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cell models and their application for studying adipogenic differentiation in relation to obesity: a review</article-title><source>International Journal of Molecular Sciences</source><volume>17</volume><elocation-id>1040</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17071040</pub-id><pub-id pub-id-type="pmid">27376273</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakers</surname><given-names>A</given-names></name><name><surname>De Siqueira</surname><given-names>MK</given-names></name><name><surname>Seale</surname><given-names>P</given-names></name><name><surname>Villanueva</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Adipose-Tissue plasticity in health and disease</article-title><source>Cell</source><volume>185</volume><fpage>419</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.12.016</pub-id><pub-id pub-id-type="pmid">35120662</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamsi</surname><given-names>F</given-names></name><name><surname>Tseng</surname><given-names>YH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Protocols for generation of immortalized human brown and white preadipocyte cell lines</article-title><source>Methods in Molecular Biology</source><volume>1566</volume><fpage>77</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6820-6_8</pub-id><pub-id pub-id-type="pmid">28244042</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Duchen</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Analysis of organization and activity of mitochondrial respiratory chain complexes in primary fibroblasts using blue native page</article-title><source>Methods in Molecular Biology</source><volume>2497</volume><fpage>339</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-2309-1_25</pub-id><pub-id pub-id-type="pmid">35771456</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Gene -- environment-wide association studies: emerging approaches</article-title><source>Nature Reviews. Genetics</source><volume>11</volume><fpage>259</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1038/nrg2764</pub-id><pub-id pub-id-type="pmid">20212493</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toledo</surname><given-names>FGS</given-names></name><name><surname>Menshikova</surname><given-names>EV</given-names></name><name><surname>Ritov</surname><given-names>VB</given-names></name><name><surname>Azuma</surname><given-names>K</given-names></name><name><surname>Radikova</surname><given-names>Z</given-names></name><name><surname>DeLany</surname><given-names>J</given-names></name><name><surname>Kelley</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes</article-title><source>Diabetes</source><volume>56</volume><fpage>2142</fpage><lpage>2147</lpage><pub-id pub-id-type="doi">10.2337/db07-0141</pub-id><pub-id pub-id-type="pmid">17536063</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tormos</surname><given-names>KV</given-names></name><name><surname>Anso</surname><given-names>E</given-names></name><name><surname>Hamanaka</surname><given-names>RB</given-names></name><name><surname>Eisenbart</surname><given-names>J</given-names></name><name><surname>Joseph</surname><given-names>J</given-names></name><name><surname>Kalyanaraman</surname><given-names>B</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mitochondrial complex III ROS regulate adipocyte differentiation</article-title><source>Cell Metabolism</source><volume>14</volume><fpage>537</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.08.007</pub-id><pub-id pub-id-type="pmid">21982713</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Grishin</surname><given-names>D</given-names></name><name><surname>Rios</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>LY</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Church</surname><given-names>GM</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Efficient, footprint-free human iPSC genome editing by consolidation of cas9/CRISPR and piggyBac technologies</article-title><source>Nature Protocols</source><volume>12</volume><fpage>88</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.152</pub-id><pub-id pub-id-type="pmid">27929521</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>LD</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>D930</fpage><lpage>D934</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr917</pub-id><pub-id pub-id-type="pmid">22064851</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>FY</given-names></name><name><surname>Taylor</surname><given-names>WA</given-names></name><name><surname>Hurd</surname><given-names>JA</given-names></name><name><surname>Hatch</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Etomoxir mediates differential metabolic channeling of fatty acid and glycerol precursors into cardiolipin in H9c2 cells</article-title><source>Journal of Lipid Research</source><volume>44</volume><fpage>415</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1194/jlr.M200335-JLR200</pub-id><pub-id pub-id-type="pmid">12576524</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>R</given-names></name><name><surname>Lynes</surname><given-names>MD</given-names></name><name><surname>Dreyfuss</surname><given-names>JM</given-names></name><name><surname>Shamsi</surname><given-names>F</given-names></name><name><surname>Schulz</surname><given-names>TJ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>TL</given-names></name><name><surname>Townsend</surname><given-names>KL</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Weiner</surname><given-names>LS</given-names></name><name><surname>White</surname><given-names>AP</given-names></name><name><surname>Lynes</surname><given-names>MS</given-names></name><name><surname>Rubin</surname><given-names>LL</given-names></name><name><surname>Goodyear</surname><given-names>LJ</given-names></name><name><surname>Cypess</surname><given-names>AM</given-names></name><name><surname>Tseng</surname><given-names>Y-H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Clonal analyses and gene profiling identify genetic biomarkers of the thermogenic potential of human brown and white preadipocytes</article-title><source>Nature Medicine</source><volume>21</volume><fpage>760</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1038/nm.3881</pub-id><pub-id pub-id-type="pmid">26076036</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>An</surname><given-names>YA</given-names></name><name><surname>Scherer</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mitochondrial regulation and white adipose tissue homeostasis</article-title><source>Trends in Cell Biology</source><volume>32</volume><fpage>351</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2021.10.008</pub-id><pub-id pub-id-type="pmid">34810062</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene<break/>(<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">MTIF3</td><td align="left" valign="bottom">UCSC Genome Browser</td><td align="left" valign="bottom">GRCh38/hg38</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line<break/>(<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">hWAs</td><td align="left" valign="bottom">Tseng laboratory at Joslin Diabetes Center</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib45">Xue et al., 2015</xref></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line<break/>(<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">hWAs-iCas9</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Cell line maintained at Lund University <break/>Diabetes Center</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-MTIF3 (rabbit polyclonal antibody)</td><td align="left" valign="bottom">Proteintech</td><td align="left" valign="bottom">Cat: 14219-1-AP</td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-OXPHOS antibody cocktail (mouse polyclonal antibody)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat: 45-8199</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FABP4 (rabbit polyclonal antibody)</td><td align="left" valign="bottom">Cell Signalling Technology</td><td align="left" valign="bottom">Cat: 12589</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ACC rabbit polyclonal antibody</td><td align="left" valign="bottom">Cell Signalling Technology</td><td align="left" valign="bottom">Cat: 12589</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FAS rabbit polyclonal antibody</td><td align="left" valign="bottom">Cell Signalling Technology</td><td align="left" valign="bottom">Cat: 12589</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ATP8<break/>(rabbit polyclonal antibody)</td><td align="left" valign="bottom">Proteintech</td><td align="left" valign="bottom">Cat: 26723-1-AP</td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ND2 (rabbit polyclonal antibody)</td><td align="left" valign="bottom">Proteintech</td><td align="left" valign="bottom">Cat: 19704-1-AP</td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CYTB (rabbit polyclonal antibody)</td><td align="left" valign="bottom">Proteintech</td><td align="left" valign="bottom">Cat: 55090-1-AP</td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-Actin (rabbit polyclonal antibody)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat: #4967</td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GAPDH (rabbit polyclonal antibody)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat: ab37168</td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG, HRP-linked Antibody (goat polyclonal antibody)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat: #7074</td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG, HRP-linked Antibody (horse polyclonal antibody)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat: #7076</td><td align="left" valign="bottom">WB (1:10,000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Super PiggyBac transposase (plasmid)</td><td align="left" valign="bottom">System Biosciences</td><td align="left" valign="bottom">PB210PA-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGL4.23 vectors</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">E8411</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGL4.75 CMV-Renilla reporter vectors</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">E6931</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pPB-rtTA-hCas9-puro-PB plasmid</td><td align="left" valign="bottom">doi:10.1038/nprot.2016.152</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primer (Forward) for rs67785913 genotyping</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><named-content content-type="sequence">5′–3′: GATTTGCAGGTGAGCAGACA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">PCR primer (Reverse) for rs67785913 genotyping</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><named-content content-type="sequence">5′–3′: ACTTGGAAATGGCCAAGATG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">sgRNA for rs67785913 editing</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Spacer sequence: <named-content content-type="sequence">5′-TTCAATAAGAAATTCCTCAA-3′</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">sgRNA for rs67785913 editing</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Spacer sequence: <named-content content-type="sequence">5′-GAAGAAAAAGGGGGGACACG-3</named-content>′</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Donor template for rs67785913 editing</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom"/><td align="left" valign="bottom">ssDNA sequence:<break/><named-content content-type="sequence">5′’TGTGGACTCGCAGTCTGCCCTTGAGGAATTTCTTATTGAAGAAGAAAAAGAGGGGGGACACGGGGCCCAGACCCCCAGCACCCGGCTTTCGAGCAGGCTC-3′</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">sgRNA against MTIF3</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">Design ID: Hs.Cas9.MTIF3.1.AB</td><td align="left" valign="bottom">Spacer sequence:<break/>5′-GCAATAGGGGACAA<break/>CTGTGC-3′<break/></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>MTIF3</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs00794538_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>GTF3A</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs00157851_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>ADIPOQ</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs00977214_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>PPARG</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs01115513_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>CEBPA</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs00269972_s1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>SREBF1</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs02561944_s1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>FASN</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs01005622_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>TFAM</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs01073348_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>MT-CO1</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs02596864_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>PRDM16</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs00223161_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>TOMM20</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs03276810_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>CPT1B</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs00189258_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>ACADM</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom"><italic>Hs00936584_m1</italic></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>ACAT1</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs00608002_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>ABHD5</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs01104373_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>PNP1A2</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs00386101_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>ACACB</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs01565914_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>MT-ND1</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs02596873_s1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>MT-ND2</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs02596874_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>MT-ND3</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs02596875_s1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>MT-ND4</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs02596876_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>MT-CO2</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs02596865_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>MT-CO3</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs02596866_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>HPRT-1</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs99999909_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>TBP</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs00427620_m1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Taqman assay for <italic>RPL13A</italic></td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Hs03043885_g1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">DNeasy Blood and Tissue kit</td><td align="left" valign="bottom">QIAGEN</td><td align="char" char="." valign="bottom">69506</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Dual-Glo Stop&amp;Glo reagents</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">E2920</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Alt-R S.p. Cas9 D10A Nickase V3</td><td align="left" valign="bottom">IDT</td><td align="char" char="." valign="bottom">1081058</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Nucleofector reagent L</td><td align="left" valign="bottom">Lonza</td><td align="left" valign="bottom">VCA-1005</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Alt-R HDR Enhancer V2</td><td align="left" valign="bottom">IDT</td><td align="char" char="." valign="bottom">10007921</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QuickExtract DNA Extraction Solution</td><td align="left" valign="bottom">Lucigen</td><td align="left" valign="bottom">QE09050</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Alt-R Genome Editing Detection Kit</td><td align="left" valign="bottom">IDT</td><td align="char" char="." valign="bottom">1075932</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Mitochondrial isolation kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">89874</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NativePAGE Sample Prep Kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">BN2008</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Quant-iT PicoGreen dsDNA Assay Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">P7589</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Triglyceride-Glo Assay kit</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">J3161</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Glycerol-Glo Assay</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">J3150</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Insulin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">I2643</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Isoproterenol</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="char" char="." valign="bottom">1351005</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Glucose</td><td align="left" valign="bottom">Angilent</td><td align="char" char="ndash" valign="bottom">103577-100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Glutamine</td><td align="left" valign="bottom">Angilent</td><td align="char" char="ndash" valign="bottom">103579-100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Carnitine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C0283</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Pyridine</td><td align="left" valign="bottom">Thermo Scientific</td><td align="char" char="." valign="bottom">019378.K2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom"><italic>N</italic>-Methyl-<italic>N</italic>-(trimethylsilyl) trifluoroacetamide</td><td align="left" valign="bottom">Thermo Scientific</td><td align="left" valign="bottom">A13141.22</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Trimethylsilyl chloride</td><td align="left" valign="bottom">Thermo Scientific</td><td align="left" valign="bottom">A12535.30</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">3-Nitrophenylhydrazine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">N21804</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride</td><td align="left" valign="bottom">Thermo Scientific</td><td align="char" char="." valign="bottom">22980</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Formic acid</td><td align="left" valign="bottom">Fisher Chemical</td><td align="left" valign="bottom">A117-50</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Etomoxir</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">E1905</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Oligomycin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">O4876</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FCCP</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C2920</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Rotenone</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">R8875</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Antimycin A</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A8674</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84168.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Seldin</surname><given-names>Marcus M</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gyf1771</institution-id><institution>University of California</institution></institution-wrap><addr-line><named-content content-type="city">Irvine</named-content></addr-line><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.10.16.512435" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.16.512435"/></front-stub><body><p>In this study, Huang et al. perform detailed functional genomics assays in cultured adipocytes to provide mechanistic insight underlying an important obesity GWAS locus. These studies not only demonstrate allele-specific effects of MITF3 as a potential causal gene for variations in rs67785913 and rs1885988 alleles, but further provide a foundational framework from bridging GWAS associations to actionable pathways. The study strengths include genetic manipulation followed by detailed biochemical characterization to mimic and test the impacts of association, where future studies potentially involving in vivo characterizations could further inform the metabolic consequences of these observations.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84168.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Seldin</surname><given-names>Marcus M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gyf1771</institution-id><institution>University of California</institution></institution-wrap><addr-line><named-content content-type="city">Irvine</named-content></addr-line><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Hartig</surname><given-names>Sean M</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Baylor College of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.16.512435">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.10.16.512435v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Identification of a weight loss-associated causal eQTL in MTIF3 and the effects of MTIF3 deficiency on human adipocyte function&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and David James as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Sean M. Hartig (Reviewer #1).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission. We all remain enthusiastic about the implications of these functional genomics experiments characterizing the locus and most requested revisions surround more detailed evaluation primarily in cell culture models used.</p><p>Essential revisions:</p><p>As you will see below, the primary suggestions for improving the study lie in more detailed molecular and functional characterization of MTIF3 and the effects of the locus. A few of these include protein quantification and staining (oil red O) for adipocytes where MTIF3 is perturbed. In addition, the reviewers requested a few text-based clarifications regarding the interpretation of the locus, listed below. Obviously, if you have any questions feel, please free to reach out.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>It is important to point out that adipocyte differentiation and the expression of the associated metabolic programs critically contribute to the maintenance of insulin sensitivity in obesity. Defects in adipocyte differentiation derived from mitochondrial functions that reduce ATP synthesis and storage of surfeit carbons in fat tissue almost always associate with insulin resistance in animal models and people (see Trends Cell Biol 32:351-364, 2022; Cell. 185:419-446, 2022). The in vitro studies can add to understanding the important roles of MTIF3, but the authors should use more caution when extrapolating to in vivo effects of the eQTL.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. The authors should give their hypothesis and interpretation of their results in the manuscript. There are no clear connections between results, which makes it difficult to understand the rationale of their experiments.</p><p>2. The labels of Figure 1 do not match the figure legends.</p><p>3. In figure 1F, what is the readout of the relative MTIF3expression? Are they based on western blot? If yes, it would be better to include the blog images.</p><p>4. In the method, the authors also added extra lipids in the differentiated medium to increase the lipid droplets. I'm curious about the effect of lipid deprivation in KO cells rather than glucose deprivation. The metabolomics showed the change of fatty acids at full medium. There might be some changes in fatty acid utilization in KO cells.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84168.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>As you will see below, the primary suggestions for improving the study lie in more detailed molecular and functional characterization of MTIF3 and the effects of the locus. A few of these include protein quantification and staining (oil red O) for adipocytes where MTIF3 is perturbed. In addition, the reviewers requested a few text-based clarifications regarding the interpretation of the locus, listed below. Obviously, if you have any questions feel, please free to reach out.</p></disp-quote><p>We thank for all the comments and suggestions the editors and reviewers made to help us improve our manuscript. We marked all the changes we made in the revised manuscript in yellow, and we also included an Appendix key resources table to list all the reagents we used in this study. Note that we also removed the p values and n (sample size) numbers in the main text, as they are already listed in the figures and figure legends. We also corrected some typos that were missed in the original manuscript. Furthermore, to meet the revision submission guidelines, we have included Key Resources Table as an appendix at the end of the manuscript, reformatted previous supplemental tables as Supplementary files 1a and 1b, and added legends to source files (uncropped blot images, and raw data files).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>It is important to point out that adipocyte differentiation and the expression of the associated metabolic programs critically contribute to the maintenance of insulin sensitivity in obesity. Defects in adipocyte differentiation derived from mitochondrial functions that reduce ATP synthesis and storage of surfeit carbons in fat tissue almost always associate with insulin resistance in animal models and people (see Trends Cell Biol 32:351-364, 2022; Cell. 185:419-446, 2022). The in vitro studies can add to understanding the important roles of MTIF3, but the authors should use more caution when extrapolating to in vivo effects of the eQTL.</p></disp-quote><p>We have now incorporated your suggestion, and expanded on it in the manuscript (lines 294-311).</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. The authors should give their hypothesis and interpretation of their results in the manuscript. There are no clear connections between results, which makes it difficult to understand the rationale of their experiments.</p></disp-quote><p>Thank you for your suggestions. In the revised manuscript, we have included the hypotheses in the introduction (Lines: 70-76) and added or clarified the rationale behind the experiments in several paragraphs of the results (lines: 104-116, 138-140, 159-161, 170-171, 182-183, 199-200, 215-216). We also added more interpretation of our data to the discussion, among the highlighted parts, and the summary statement in lines 321-331.</p><disp-quote content-type="editor-comment"><p>2. The labels of Figure 1 do not match the figure legends.</p></disp-quote><p>We have corrected this error in the revised manuscript in the figure legend.</p><disp-quote content-type="editor-comment"><p>3. In figure 1F, what is the readout of the relative MTIF3expression? Are they based on western blot? If yes, it would be better to include the blog images.</p></disp-quote><p>In Figure 1F, the relative <italic>MTIF3</italic> expression represents mRNA level based on RT-qPCR assay. We have clarified that in the revised figure legend (lines 803, 806).</p><disp-quote content-type="editor-comment"><p>4. In the method, the authors also added extra lipids in the differentiated medium to increase the lipid droplets. I'm curious about the effect of lipid deprivation in KO cells rather than glucose deprivation. The metabolomics showed the change of fatty acids at full medium. There might be some changes in fatty acid utilization in KO cells.</p></disp-quote><p>We might not have been clear on this in the original manuscript – we only use extra lipids during the differentiation process. Then, after generating the knockout and during the restriction experiments, the adipocytes are maintained in medium <italic>without</italic> extra lipids, to ensure more efficient lipolysis. In other words, your suggestion for lipid deprivation has already been met in our experiments. We have clarified that in the methods (lines: 432-439) and in the results (line 192). As you suggest, the fatty acid utilization is affected by the <italic>MTIF3</italic> knockout, as demonstrated by the changed metabolite profile (Figure 7) and fatty acid oxidation (Figure 6).</p><p>References</p><p>1. Rudler, D.L., et al., <italic>Fidelity of translation initiation is required for coordinated respiratory complex assembly.</italic> Sci Adv, 2019. 5(12): p. eaay2118.</p><p>2. Renes, J., et al., <italic>Calorie restriction-induced changes in the secretome of human adipocytes, comparison with resveratrol-induced secretome effects.</italic> Biochim Biophys Acta, 2014. 1844(9): p. 1511-22.movie</p></body></sub-article></article>